US20220389467A1 - Biosynthetic production of psilocybin and related intermediates in recombinant organisms - Google Patents
Biosynthetic production of psilocybin and related intermediates in recombinant organisms Download PDFInfo
- Publication number
- US20220389467A1 US20220389467A1 US17/878,858 US202217878858A US2022389467A1 US 20220389467 A1 US20220389467 A1 US 20220389467A1 US 202217878858 A US202217878858 A US 202217878858A US 2022389467 A1 US2022389467 A1 US 2022389467A1
- Authority
- US
- United States
- Prior art keywords
- seq
- recombinant host
- amino acid
- host organism
- psilocybin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- QVDSEJDULKLHCG-UHFFFAOYSA-N Psilocybine Natural products C1=CC(OP(O)(O)=O)=C2C(CCN(C)C)=CNC2=C1 QVDSEJDULKLHCG-UHFFFAOYSA-N 0.000 title claims abstract description 147
- QKTAAWLCLHMUTJ-UHFFFAOYSA-N psilocybin Chemical compound C1C=CC(OP(O)(O)=O)=C2C(CCN(C)C)=CN=C21 QKTAAWLCLHMUTJ-UHFFFAOYSA-N 0.000 title claims abstract 7
- 239000000543 intermediate Substances 0.000 title description 23
- 230000015572 biosynthetic process Effects 0.000 title description 6
- 238000000034 method Methods 0.000 claims abstract description 29
- 108090000623 proteins and genes Proteins 0.000 claims description 135
- 150000001413 amino acids Chemical group 0.000 claims description 51
- 108020004705 Codon Proteins 0.000 claims description 47
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 21
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 21
- 241000894007 species Species 0.000 claims description 13
- 230000002538 fungal effect Effects 0.000 claims description 11
- 241000235346 Schizosaccharomyces Species 0.000 claims description 7
- 241000500435 Kluyveromyces dobzhanskii Species 0.000 claims description 6
- 241001138401 Kluyveromyces lactis Species 0.000 claims description 6
- 241000025833 Schizosaccharomyces cryophilus Species 0.000 claims description 6
- 241000235348 Schizosaccharomyces japonicus Species 0.000 claims description 6
- 241000235347 Schizosaccharomyces pombe Species 0.000 claims description 6
- 241000235015 Yarrowia lipolytica Species 0.000 claims description 6
- 108010078791 Carrier Proteins Proteins 0.000 claims description 5
- 229930091371 Fructose Natural products 0.000 claims description 5
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 5
- 239000005715 Fructose Substances 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 108060004795 Methyltransferase Proteins 0.000 claims description 5
- 102000016397 Methyltransferase Human genes 0.000 claims description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 5
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 5
- 229930182830 galactose Natural products 0.000 claims description 5
- 230000014509 gene expression Effects 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 235000013379 molasses Nutrition 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- 230000002194 synthesizing effect Effects 0.000 claims description 5
- 108030004131 4-hydroxytryptamine kinases Proteins 0.000 claims description 3
- 108030005763 L-tryptophan decarboxylases Proteins 0.000 claims description 3
- 108030006255 Tryptamine 4-monooxygenases Proteins 0.000 claims description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 abstract description 65
- 102000004190 Enzymes Human genes 0.000 abstract description 61
- 108090000790 Enzymes Proteins 0.000 abstract description 61
- 229960004799 tryptophan Drugs 0.000 abstract description 33
- 239000002243 precursor Substances 0.000 abstract description 16
- 230000002068 genetic effect Effects 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 2
- 230000037361 pathway Effects 0.000 description 46
- 241000332761 Psilocybe cyanescens Species 0.000 description 23
- SPCIYGNTAMCTRO-UHFFFAOYSA-N psilocin Chemical compound C1=CC(O)=C2C(CCN(C)C)=CNC2=C1 SPCIYGNTAMCTRO-UHFFFAOYSA-N 0.000 description 22
- 241001062357 Psilocybe cubensis Species 0.000 description 19
- 241000693045 Gymnopilus spectabilis Species 0.000 description 18
- IKQGYCWFBVEAKF-UHFFFAOYSA-N norbaeocystin Chemical compound C1=CC(OP(O)(O)=O)=C2C(CCN)=CNC2=C1 IKQGYCWFBVEAKF-UHFFFAOYSA-N 0.000 description 18
- 150000007523 nucleic acids Chemical group 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 17
- APJYDQYYACXCRM-UHFFFAOYSA-N tryptamine Chemical compound C1=CC=C2C(CCN)=CNC2=C1 APJYDQYYACXCRM-UHFFFAOYSA-N 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 230000004151 fermentation Effects 0.000 description 13
- 238000000855 fermentation Methods 0.000 description 13
- 230000004907 flux Effects 0.000 description 13
- 229940024606 amino acid Drugs 0.000 description 12
- WTPBXXCVZZZXKR-UHFFFAOYSA-N baeocystin Chemical compound C1=CC(OP(O)(O)=O)=C2C(CCNC)=CNC2=C1 WTPBXXCVZZZXKR-UHFFFAOYSA-N 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 11
- 101150114788 ARO4 gene Proteins 0.000 description 10
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- FKIRTWDHOWAQGX-UHFFFAOYSA-N 4-hydroxytryptamine Chemical compound C1=CC(O)=C2C(CCN)=CNC2=C1 FKIRTWDHOWAQGX-UHFFFAOYSA-N 0.000 description 9
- 241000598817 Gymnopilus dilepis Species 0.000 description 8
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 8
- WTFXTQVDAKGDEY-UHFFFAOYSA-N (-)-chorismic acid Natural products OC1C=CC(C(O)=O)=CC1OC(=C)C(O)=O WTFXTQVDAKGDEY-UHFFFAOYSA-N 0.000 description 7
- 101150058005 ARO3 gene Proteins 0.000 description 7
- 240000008042 Zea mays Species 0.000 description 7
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 7
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 7
- WTFXTQVDAKGDEY-HTQZYQBOSA-N chorismic acid Chemical compound O[C@@H]1C=CC(C(O)=O)=C[C@H]1OC(=C)C(O)=O WTFXTQVDAKGDEY-HTQZYQBOSA-N 0.000 description 7
- 235000005822 corn Nutrition 0.000 description 7
- 238000006366 phosphorylation reaction Methods 0.000 description 7
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 6
- 101710163881 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 description 6
- 102100031413 L-dopachrome tautomerase Human genes 0.000 description 6
- 241001236144 Panaeolus Species 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 6
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 6
- 230000002503 metabolic effect Effects 0.000 description 6
- 239000002773 nucleotide Substances 0.000 description 6
- 125000003729 nucleotide group Chemical group 0.000 description 6
- 230000026731 phosphorylation Effects 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 101150026818 trp3 gene Proteins 0.000 description 6
- LKKMLIBUAXYLOY-UHFFFAOYSA-N 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1C=C(N)N=C2C LKKMLIBUAXYLOY-UHFFFAOYSA-N 0.000 description 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 5
- 101500018095 Apis mellifera APMGFYGTR-amide Proteins 0.000 description 5
- 101100208128 Arabidopsis thaliana TSA1 gene Proteins 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 5
- 102000053602 DNA Human genes 0.000 description 5
- 101710093778 L-dopachrome tautomerase Proteins 0.000 description 5
- 101100002656 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ARO2 gene Proteins 0.000 description 5
- 101100435911 Solanum tuberosum SHKB gene Proteins 0.000 description 5
- 102000003629 TRPC3 Human genes 0.000 description 5
- 102000003622 TRPC4 Human genes 0.000 description 5
- 101150037542 Trpc3 gene Proteins 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 238000006114 decarboxylation reaction Methods 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 4
- 101000919395 Homo sapiens Aromatase Proteins 0.000 description 4
- 101100082596 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) PDC5 gene Proteins 0.000 description 4
- 101100152436 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) TAT2 gene Proteins 0.000 description 4
- 102000003627 TRPC1 Human genes 0.000 description 4
- 230000029936 alkylation Effects 0.000 description 4
- 238000005804 alkylation reaction Methods 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 230000033444 hydroxylation Effects 0.000 description 4
- 238000005805 hydroxylation reaction Methods 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 238000002888 pairwise sequence alignment Methods 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 150000003141 primary amines Chemical class 0.000 description 4
- 102200061168 rs150338273 Human genes 0.000 description 4
- PJWIPEXIFFQAQZ-PUFIMZNGSA-N 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonic acid Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@H](O)CC(=O)C(O)=O PJWIPEXIFFQAQZ-PUFIMZNGSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 102100029361 Aromatase Human genes 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 101100246753 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) pyrF gene Proteins 0.000 description 3
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 3
- 229930182816 L-glutamine Natural products 0.000 description 3
- 108091000080 Phosphotransferase Proteins 0.000 description 3
- 101150050575 URA3 gene Proteins 0.000 description 3
- -1 aromatic alcohols Chemical class 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 150000002475 indoles Chemical class 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 230000004630 mental health Effects 0.000 description 3
- 230000011987 methylation Effects 0.000 description 3
- 238000007069 methylation reaction Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000002018 overexpression Effects 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 102000020233 phosphotransferase Human genes 0.000 description 3
- 229920002477 rna polymer Polymers 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 229960001153 serine Drugs 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- QSHLMQDRPXXYEE-ZETCQYMHSA-N 4-hydroxy-L-tryptophan Chemical compound C1=CC(O)=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QSHLMQDRPXXYEE-ZETCQYMHSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 108090000489 Carboxy-Lyases Proteins 0.000 description 2
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 2
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 2
- 241001059395 Panaeolus cyanescens Species 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- DCBDOYDVQJVXOH-UHFFFAOYSA-N azane;1h-indole Chemical compound N.C1=CC=C2NC=CC2=C1 DCBDOYDVQJVXOH-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- GNGACRATGGDKBX-UHFFFAOYSA-N dihydroxyacetone phosphate Chemical compound OCC(=O)COP(O)(O)=O GNGACRATGGDKBX-UHFFFAOYSA-N 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 238000012268 genome sequencing Methods 0.000 description 2
- 230000034659 glycolysis Effects 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 230000000269 nucleophilic effect Effects 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 208000020016 psychiatric disease Diseases 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 150000003230 pyrimidines Chemical class 0.000 description 2
- 238000011935 selective methylation Methods 0.000 description 2
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 2
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- 101150044672 ARO1 gene Proteins 0.000 description 1
- 101150116475 ARO2 gene Proteins 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 238000006611 Barton decarboxylation reaction Methods 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 101100365490 Drosophila melanogaster Jon99Ci gene Proteins 0.000 description 1
- 101100533228 Drosophila melanogaster Jon99Cii gene Proteins 0.000 description 1
- 101100533231 Drosophila melanogaster Jon99Ciii gene Proteins 0.000 description 1
- 101150034423 GLN1 gene Proteins 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 125000002707 L-tryptophyl group Chemical group [H]C1=C([H])C([H])=C2C(C([C@](N([H])[H])(C(=O)[*])[H])([H])[H])=C([H])N([H])C2=C1[H] 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 101150031367 PDC5 gene Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 108030000769 Psilocybin synthases Proteins 0.000 description 1
- 101150052146 SER2 gene Proteins 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 101100216804 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ARO10 gene Proteins 0.000 description 1
- 101100533233 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) SER33 gene Proteins 0.000 description 1
- 101100240646 Scheffersomyces stipitis (strain ATCC 58785 / CBS 6054 / NBRC 10063 / NRRL Y-11545) NMA111 gene Proteins 0.000 description 1
- 101150089984 TAT2 gene Proteins 0.000 description 1
- 101150006914 TRP1 gene Proteins 0.000 description 1
- 101150088964 TRP4 gene Proteins 0.000 description 1
- 241000235013 Yarrowia Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
- 230000008850 allosteric inhibition Effects 0.000 description 1
- 150000001412 amines Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 230000000949 anxiolytic effect Effects 0.000 description 1
- 101150032070 aro7 gene Proteins 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 230000030609 dephosphorylation Effects 0.000 description 1
- 238000006209 dephosphorylation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 230000008713 feedback mechanism Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 230000004110 gluconeogenesis Effects 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000002013 hydrophilic interaction chromatography Methods 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 208000024714 major depressive disease Diseases 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- KLAKIAVEMQMVBT-UHFFFAOYSA-N p-hydroxy-phenacyl alcohol Natural products OCC(=O)C1=CC=C(O)C=C1 KLAKIAVEMQMVBT-UHFFFAOYSA-N 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 208000022821 personality disease Diseases 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 102000034272 protein filaments Human genes 0.000 description 1
- 108091005974 protein filaments Proteins 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012776 robust process Methods 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 101150106567 ser1 gene Proteins 0.000 description 1
- 101150008449 ser3 gene Proteins 0.000 description 1
- 108020001482 shikimate kinase Proteins 0.000 description 1
- JXOHGGNKMLTUBP-HSUXUTPPSA-N shikimic acid Chemical compound O[C@@H]1CC(C(O)=O)=C[C@@H](O)[C@H]1O JXOHGGNKMLTUBP-HSUXUTPPSA-N 0.000 description 1
- JXOHGGNKMLTUBP-JKUQZMGJSA-N shikimic acid Natural products O[C@@H]1CC(C(O)=O)=C[C@H](O)[C@@H]1O JXOHGGNKMLTUBP-JKUQZMGJSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- KXCAEQNNTZANTK-UHFFFAOYSA-N stannane Chemical class [SnH4] KXCAEQNNTZANTK-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 210000003956 transport vesicle Anatomy 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- C12N9/0083—Miscellaneous (1.14.99)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
- C12N9/1007—Methyltransferases (general) (2.1.1.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/10—Nitrogen as only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y205/00—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
- C12Y205/01—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
- C12Y205/01054—3-Deoxy-7-phosphoheptulonate synthase (2.5.1.54)
Definitions
- the Sequence Listing which is a part of the present disclosure, includes a computer readable form and a written sequence listing comprising nucleotide and/or amino acid sequences of the present invention.
- the sequence listing information recorded in computer readable form is identical to the written sequence listing.
- the subject matter of the Sequence Listing is incorporated herein by reference in its entirety.
- the present invention generally relates to the production of psilocybin and its intermediates (e.g., tryptamine, 4-hydroxytryptamine, norbaeocystin, baeocystin, and psilocin) in a modified heterologous microorganism.
- psilocybin and its intermediates e.g., tryptamine, 4-hydroxytryptamine, norbaeocystin, baeocystin, and psilocin
- Mental health problems which may also be referred to as mental illness or psychiatric disorder, are behavioral or mental patterns which impair the functioning of individuals across the world. Psilocybin has been increasingly evaluated for treating mental health problems. Such mental health disorders include: personality disorders, anxiety disorders, major depressions, and various addictions. In contrast to anxiolytic medicines, usage of psilocybin does not lead to physical dependence.
- the present teachings include a recombinant host organism.
- the recombinant host organism can include: a plurality of cells transfected by a set of genes for synthesizing psilocybin in the recombinant host organism via at least a first pathway and a second pathway.
- the recombinant host organism can be a fungal species comprising: Schizosaccharomyces cerevisiae, Schizosaccharomyces japonicus, Schizosaccharomyces pombe, Schizosaccharomyces cryophilus, Saccharomyces cerevisiae, Kluyveromyces lactis, Kluyveromyces dobzhanskii , and Yarrowia lipolytica .
- the set of genes can include any combination of a gene selected from a group consisting of PsiD, PsiH, PsiK, and PsiM.
- PsiD can comprise codon optimized nucleic acid sequences SEQ ID NO: 1, SEQ ID NO: 2, and SEQ ID NO: 3 that encode for isolated amino acid sequences SEQ ID NO: 14, SEQ ID NO: 15, and SEQ ID NO: 16, respectively;
- PsiH can comprise codon optimized nucleic acid sequences SEQ ID NO: 4, SEQ ID NO: 5, and SEQ ID NO: 6 that encode for isolated amino acid sequences SEQ ID NO: 17 SEQ ID NO: 18, and SEQ ID NO: 19, respectively;
- PsiK can comprise codon optimized nucleic acid sequences SEQ ID NO: 7 and SEQ ID NO: 8 that encode for isolated amino acid sequences SEQ ID NO: 20 and SEQ ID NO: 21, respectively;
- PsiM can comprises codon optimized nucleic acid sequences SEQ ID NO: 9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO: 12, and SEQ ID NO: 13 that encode for isolated amino acid sequences SEQ ID NO: 22, SEQ ID NO: 23,
- the set of genes can express amino acid sequences that increase titers of psilocybin in the plurality of cells.
- the set of genes can synthesize intermediates of psilocybin, wherein the intermediates comprise: tryptamine, 4-hydroxytryptamine, norbaeocystin, baeocystin, and psilocin.
- a protein can be heterologous to the plurality of cells and an exogenous substrate, wherein the protein is encoded by codon optimized SEQ ID NO: 36.
- the carbon source can include at least one of: glucose, galactose, sucrose, fructose, corn syrup, corn steep liquor, ethanol, and molasses.
- the first pathway can be a shikimate-chorismate pathway and the second pathway can be a L-tryptophan pathway
- the first pathway can be modified by codon optimized SEQ ID NO: 27, SEQ ID NO. 28, SEQ ID NO: 29, SEQ ID NO: 30, and SEQ ID NO: 31 and the second pathway is modified by codon optimized SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO: 34, and SEQ ID NO: 35.
- the present teaching include a plurality of sequences containing nucleotides or amino acids for producing psilocybin in a recombinant host organism, wherein the plurality of sequences comprise SEQ ID NO: 1-SEQ ID NO: 36.
- an isolated amino acid sequence comprises SEQ ID NO: 14, SEQ ID NO: 15, and SEQ ID NO: 16, wherein SEQ ID NO: 14, SEQ ID NO: 15, and SEQ ID NO: 16 can be at least 50% similar to each other, and wherein SEQ ID NO: 14 is encoded by codon optimized SEQ ID NO: 1, SEQ ID NO: 15 is encoded by codon optimized SEQ ID NO: 2, and SEQ ID NO: 16 is encoded by codon optimized SEQ ID NO: 3.
- an isolated amino acid sequence comprises at least one of: SEQ ID NO: 17, SEQ ID NO: 18, and SEQ ID NO: 19, wherein SEQ ID NO: 17, SEQ ID NO: 18, and SEQ ID NO: 19 are at least 40% similar to each other, and wherein SEQ ID NO: 17 is encoded by codon optimized SEQ ID NO: 4, SEQ ID NO: 18 is encoded by codon optimized SEQ ID NO: 5, and SEQ ID NO: 19 is encoded by codon optimized SEQ ID NO: 6.
- an isolated amino acid sequence comprises at least one of: SEQ ID NO: 20 and SEQ ID NO: 21, wherein SEQ ID NO: 20 and SEQ ID NO: 21 are at least 85% similar to each other; and wherein SEQ ID NO: 21 is encoded by codon optimized SEQ ID NO: 7 and SEQ ID NO: 22 is encoded by codon optimized SEQ ID NO: 8.
- an isolated amino acid sequence comprises at least one of: SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 25, and SEQ ID NO: 26, wherein SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 25, and SEQ ID NO: 26 are at least 55% similar to each other, and wherein SEQ ID NO: 22 is encoded by codon optimized SEQ ID NO: 9, SEQ ID NO: 23 is encoded by codon optimized SEQ ID NO: 10, SEQ ID NO: 24 is encoded by SEQ ID NO: 11, SEQ ID NO: 25 is encoded by SEQ ID NO: 12, and SEQ ID NO: 26 is encoded by SEQ ID NO: 13.
- the present teachings include a method.
- the method can include: transfecting a plurality of cells in a recombinant host organism a set of genes for synthesizing psilocybin via at least a first pathway and a second pathway; and increasing titers of psilocybin in the plurality of cells via the set of genes; and synthesizing intermediates of psilocybin via the set of genes.
- the recombinant host organism can be a fungal species comprising: Schizosaccharomyces cerevisiae, Schizosaccharomyces japonicus, Schizosaccharomyces pombe, Schizosaccharomyces cryophilus, Saccharomyces cerevisiae, Kluyveromyces lactis, Kluyveromyces dobzhanskii , and Yarrowia lipolytica .
- the set of genes can include a gene from a group consisting of: PsiD, PsiH, PsiK, and PsiM.
- PsiD can comprise codon optimized nucleic acid sequences SEQ ID NO: 1, SEQ ID NO: 2, and SEQ ID NO: 3 that encode for isolated amino acid sequences SEQ ID NO: 14, SEQ ID NO: 15, and SEQ ID NO: 16, respectively;
- PsiH can comprise codon optimized nucleic acid sequences SEQ ID NO: 4, SEQ ID NO: 5, and SEQ ID NO: 6 that encode for isolated amino acid sequences SEQ ID NO: 17, SEQ ID NO: 18, and SEQ ID NO: 19, respectively;
- PsiK can comprise codon optimized nucleic acid sequences SEQ ID NO: 7 and SEQ ID NO: 8 that encode for isolated amino acid sequences SEQ ID NO: 20 and SEQ ID NO: 21, respectively;
- PsiM can comprise codon optimized nucleic acid sequences SEQ ID NO: 9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO: 12, and SEQ ID NO: 13 that encode for isolated amino acid sequences SEQ ID NO: 22,
- the carbon source can include at least one of: glucose, galactose, sucrose, fructose, corn syrup, corn steep liquor, ethanol, and molasses.
- the method can also include an exogenous substrate and a transporter protein.
- the first pathway can be a shikimate-chorismate pathway modified by codon optimized SEQ ID NO: 27, SEQ ID NO. 28, SEQ ID NO: 29, SEQ ID NO: 30, and SEQ ID NO: 31 and the second pathway can be a L-tryptophan pathway modified by codon optimized SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO: 34, and SEQ ID NO: 35.
- the transporter protein can be encoded by codon optimized SEQ ID NO: 36.
- the intermediates can include: tryptamine, 4-hydroxytryptamine, norbaeocystin, baeocystin, and psilocin.
- FIG. 1 depicts a table of amino acids and codon triplets.
- FIG. 2 depicts a table of genes and enzymes inserted into a recombinant host organism.
- FIG. 3 depicts the biosynthesis of psilocybin.
- FIG. 4 - 7 depicts sequence alignments.
- FIG. 8 depicts endogenous pathways in a host organism.
- FIG. 9 depicts a scheme to increase metabolic flux through shikimate-chorismate and L-tryptophan pathways.
- FIG. 10 depicts a heterologous recombinant host organism.
- FIG. 11 depicts HPLC chromatograms and UV/Vis spectra.
- amino acids refer to the molecular basis for constructing and assembling proteins, such as enzymes. (See FIG. 1 for a table of amino acids.). Peptide bonds (i.e., polypeptides) are formed between amino acids and assemble three-dimensionally (3-D). The 3-D assembly can influence the properties, function, and conformational dynamics of the protein.
- the protein may: (i) catalyze reactions as enzymes; (ii) transport vesicles, molecules, and other entities within cells as transporter entities; (iii) provide structure to cells and organisms as protein filaments; (iv) replicate deoxyribonucleic acid (DNA); and (v) coordinate actions of cells as cell signalers.
- nucleotides refers to the molecular basis for constructing and assembling nucleic acids, such as DNA and ribonucleic acid (RNA).
- RNA ribonucleic acid
- purines are adenine (A) and guanine (G).
- the specific pyrimidines are cytosine (C), uracil (U), and thymine (T). T is found in DNA, whereas U is found in RNA.
- the genetic code defines the sequence of nucleotide triplets (i.e., codons) for specifying which amino acids are added during protein synthesis.
- Genes refers to regions of DNA. Amino acid sequences in the proteins, as defined by the sequence of a gene, are encoded in the genetic code.
- the present invention is directed to biosynthetic production of psilocybin and related intermediates in recombinant organisms.
- the syntheses of psilocybin and intermediates of psilocybin in a laboratory environment typically involve tedious techniques of organic chemistry. Often reproducibility is elusive and the solvents used during the syntheses of psilocybin and intermediates of psilocybin are environmentally toxic. Decarboxylations, selective methylations, and selective phosphorylations can be difficult to obtain via the techniques of organic chemistry. Further, the yields and purity of the intermediates for obtaining the target molecules can be low using the techniques of organic chemistry, where the starting molecule is L-tryptophan and the target molecule is psilocybin.
- the systems and method herein disclose more environmentally benign processes which can have higher throughputs (i.e., more robust processes).
- the systems and methods herein include: (i) growing modified recombinant host cells and thereby yielding a recombinant host organism; (ii) expressing engineered psilocybin biosynthesis genes and enzymes in the recombinant host organism; (iii) producing or synthesizing psilocybin and/or intermediates of psilocybin in the recombinant host organism; (iv) fermenting the recombinant host organism; and (v) isolating the psilocybin and/or intermediates of psilocybin from the recombinant host organism. Endogenous pathways of the recombinant host can be modified by the systems and methods herein to produce high purity psilocybin and/or intermediates of psilocybin.
- Gene source organisms provide a genetic starting source (i.e., raw gene sequences) which is codon optimized and engineered to function in the recombinant host organisms.
- the recombinant host organisms include but are not limited to: Schizosaccharomyces cerevisiae, Schizosaccharomyces japonicus, Schizosaccharomyces pombe, Schizosaccharomyces cryophilus, Saccharomyces cerevisiae, Kluyveromyces lactis, Kluyveromyces dobzhanskii , and Yarrowia lipolytica.
- genes/enzymes that are inserted or engineered into the recombinant host are PsiD, PsiH, PsiK, and PsiM.
- a PsiD enzyme which is a decarboxylase (e.g., L-tryptophan decarboxylase) derives from a gene source organism herein— Psilocybe cubensis, Psilocybe cyanescens , and Gymnopilus junonius .
- the decarboxylase can catalyze the decarboxylation of an aliphatic carboxylic acid (i.e., release carbon dioxide) L-tryptophan to tryptamine and 4-hydroxy-L-tryptophan to 4-hydroxytryptamine, as depicted in FIG. 3 .
- a PsiH enzyme which is a monooxygenase (e.g., Tryptamine 4-monooxygenase) derives from a gene source organism herein— Psilocybe cubensis, Psilocybe cyanescens , and Gymnopilus junonius .
- the monooxygenase can catalyze the oxidative hydroxylation of the phenyl ring of tryptamine to 4-hydroxytryptamine, as depicted in FIG. 3 .
- a PsiK enzyme which is a kinase (e.g., 4-hydroxytryptamine kinase) derives from a gene source organism herein— Psilocybe cubensis and Psilocybe cyanescens .
- the kinase can catalyze the phosphorylation (i.e., adding O ⁇ P(OH) 2 ) of the phenolic oxygen of 4-hydroxytryptamine to norbaeocystin, as depicted in FIG. 3 .
- the kinase can also catalyze the phosphorylation of psilocin to psilocybin.
- a PsiM enzyme which is a methyl transferase (e.g., psilocybin synthase) derives from a gene source organism herein— Psilocybe cubensis, Psilocybe cyanescens, Panaeolus cynascens, Gymnopilus junonius , and Gymnopilus dilepis .
- the methyl transferase can catalyze the alkylation (i.e., adding a methyl (CH 3 ) group) of the primary amine in norbaeocystin to baecystin, as depicted in FIG. 3 .
- Another alkylation can take place where the methyl transferase when the secondary amine of baecystin becomes a tertiary amine of psilocybin, as depicted in FIG. 3 .
- the engineered PsiD, PsiH, PsiK, and PsiM enzymes act on substrates in the psilocybin biosynthetic pathway to produce intermediates of psilocybin and psilocybin itself.
- the initial substrate for psilocybin intermediates and psilocybin can be L-tryptophan and/or 4-hydroxy-L-tryptophan.
- These initial substrates can be produced endogenously in a recombinant host as described and/or provided exogenously to a fermentation involving a recombinant host, whereby the host uptakes the starting substrates to feed into the psilocybin biosynthetic pathway.
- the recombinant host herein described that is expressing all, one, or multiple combinations of the engineered PsiD, PsiH, PsiK, PsiM genes can produce tryptamine, 4-hydroxytryptamine, norbaeocystin, baeocystin, psilocybin, and psilocin.
- Psilocybin may be converted to psilocin due to spontaneous dephosphorylation.
- Psilocin is in turn an intermediate which can be acted on by the PsiK enzyme to produce psilocybin.
- the amino acid alignments of recombinant PsiD enzymes are presented.
- Recombinant PsiD enzymes have been reengineered from various fungal species to function in heterologous recombinant host organisms herein.
- the gene used in the pair wise alignment is the PsiD gene from the fungal species— Psilocybe cubensis, Psilocybe cyanescens , and Gymnopilus junonius .
- the alignment is performed with EMBOSS Needle Pair wise Sequence Alignment statistic (EBLOSUM62) with Psilocybe cubensis (PsiD gene) as a reference.
- EBLOSUM62 EMBOSS Needle Pair wise Sequence Alignment statistic
- Psilocybe cubensis PsiD gene
- SEQ ID NO: 1 codon optimized nucleic acid sequences SEQ ID NO: 1, SEQ ID NO: 2, and SEQ ID NO: 3 encode for isolated amino acid sequences SEQ ID NO: 14, SEQ ID NO: 15, and SEQ ID NO: 16, respectively.
- SEQ ID NO: 14 is Psilocybe cubensis (PsiD gene);
- SEQ ID NO: 15 is Psilocybe cyanescens (PsiD gene);
- SEQ ID NO: 16 is Gymnopilus junonius (PsiD gene).
- the amino acid alignment of recombinant PsiH enzymes are presented.
- Recombinant PsiH enzymes have been reengineered from various fungal species to function in heterologous recombinant host organisms herein.
- the gene used in the pair wise alignment is the PsiH gene from the fungal species— Psilocybe cubensis, Psilocybe cyanescens , and Gymnopilus junonius .
- the alignment is performed with EMBOSS Needle Pair wise Sequence Alignment statistic (EBLOSUM62) with Psilocybe cubensis (PsiH gene) as a reference.
- EBLOSUM62 EMBOSS Needle Pair wise Sequence Alignment statistic
- Psilocybe cubensis PsiH gene
- SEQ ID NO: 4 codon optimized nucleic acid sequences SEQ ID NO: 4, SEQ ID NO: 5, and SEQ ID NO: 6 encode for isolated amino acid sequences SEQ ID NO: 17 SEQ ID NO: 18, and SEQ ID NO: 19, respectively.
- SEQ ID NO: 17 is Psilocybe cubensis (PsiH gene);
- SEQ ID NO: 18 is Psilocybe cyanescens (PsiH gene);
- SEQ ID NO: 19 is Gymnopilus junonius (PsiH gene).
- the amino acid alignment of recombinant PsiK enzymes are presented.
- Recombinant PsiK enzymes have been reengineered from various fungal species to function in heterologous recombinant host organisms herein.
- the gene used in the pair wise alignment is the PsiK gene from the fungal species— Psilocybe cubensis and Psilocybe cyanescens .
- the alignment is performed with EMBOSS Needle Pair wise Sequence Alignment statistic (EBLOSUM62) with Psilocybe cubensis (PsiK gene) as a reference.
- EBLOSUM62 EMBOSS Needle Pair wise Sequence Alignment statistic
- Psilocybe cubensis PsiK gene
- SEQ ID NO: 7 and SEQ ID NO: 8 encode for isolated amino acid sequences SEQ ID NO: 20 and SEQ ID NO: 21, respectively.
- SEQ ID NO: 20 is Psilocybe cubensis (PsiK gene)
- SEQ ID NO: 21 is Psilocybe cyanescens (PsiK gene).
- Recombinant PsiM enzymes have been reengineered from various fungal species to function in heterologous recombinant host organisms herein.
- the gene used in the pair wise alignment is the PsiM gene from the fungal species— Psilocybe cubensis, Psilocybe cyanescens, Panaeolus cynascens, Gymnopilus junonius , and Gymnopilus dilepis .
- the alignment is performed with EMBOSS Needle Pair wise Sequence Alignment statistic (EBLOSUM62) with Psilocybe cubensis (PsiM gene) as a reference.
- EBLOSUM62 EMBOSS Needle Pair wise Sequence Alignment statistic
- PsiM gene Psilocybe cubensis
- codon optimized nucleic acid sequences SEQ ID NO: 9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO: 12, and SEQ ID NO: 13 encode for isolated amino acid sequences SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24; SEQ ID NO: 25, and SEQ ID NO: 26, respectively.
- SEQ ID NO: 22 is Psilocybe cubensis (PsiM gene);
- SEQ ID NO: 23 is Psilocybe cyanescens (PsiM gene);
- SEQ ID NO: 24 is Panaeolus cynascens (PsiM gene);
- SEQ ID NO: 25 is Gymnopilus junonius (PsiM gene), and
- SEQ ID NO: 26 is Gymnopilus dilepis (PsiM gene).
- the endogenous pathways of a recombinant host organism produce precursors for the engineered PsiD, PsiH, PsiK, PsiM genes.
- Pathways relating to chorismate, L-glutamine, and L-serine feed into the endogenous pathway for L-tryptophan production, which a recombinant host organism expressing the psilocybin biosynthetic pathway herein described can use to create tryptamine, 4-hydroxytryptamine, norbaeocystin, baeocystin, psilocin, and psilocybin.
- the enzymes in the endogenous pathways of the recombinant host organism are encircled in FIG. 8 .
- Glycolysis and gluconeogenesis in combination with ARO3, ARO4, ARO1, and ARO2 enzymes can be subjected to the depicted precursors at the specified point in the pathway to selectively yield chrorismate.
- the glutamate biosynthesis pathway in combination with a GLN1 enzyme can be subjected to the depicted precursor at the specified point in the pathway to selectively yield L-glutamine.
- Glycolysis in combination with SER3, SER33, SER1, and SER2 enzymes can be subjected to the depicted precursors at the specified points in the pathway to selectively yield L-serine.
- Chorismate and L-glutamine in combination with TRP1, TRP2, TRP3, and TRP4 enzymes can be subjected to the depicted precursors at the specified point to selectively yield (1S,2R)-1-C-indol-3-yl)glycerol 3-phosphate.
- the addition of L-serine to (1S,2R)-1-C-indol-3-yl)glycerol 3-phosphate in the presence of the TRP1 enzyme can yield L-tryptophan.
- a scheme to increase metabolic flux through the shikimate-chorismate and L-tryptophan pathways is disclosed.
- the increased metabolic flux through the shikimate-chorismate and L-tryptophan pathways increases the production of L-tryptophan, a key precursor compound for the production of psilocybin and intermediates of psilocybin.
- Specific enzymes in the described native pathways are overexpressed. Enzymes subject to allosteric inhibition are mutated and overexpressed to render the enzymes insensitive to feedback mechanisms. Enzymes that consume pathway intermediates for off-pathway compound production are hereby deleted.
- L-tryptophan production is improved herein by overexpressing a series of enzymes that first increase production of the aromatic compound intermediate, chorismate in a series of enzymatic reactions known as the shikimate pathway.
- shikimate pathway initial precursors, PEP and E4P are converted into 3-deoxy-D-arabinoheptulosonate 7-phosphate (DAHP), catalyzed by ARO3 and ARO4 enzymes.
- DAHP 3-deoxy-D-arabinoheptulosonate 7-phosphate
- ARO3 enzyme (as encoded by codon optimized SEQ ID NO: 29), and a feedback-resistant mutant ARO4 K229L enzyme (as encoded by codon optimized SEQ ID NO: 30) are described herein and can increase metabolic flux through the pathway.
- genes that encode key enzymes, ARO1 enzyme (as encoded by codon optimized SEQ ID NO: 27) and ARO2 (as encoded by codon optimized SEQ ID NO: 28) are overexpressed as part of a series of enzymes that can convert DAHP to chorismate.
- the gene that encodes the Escherichia coli shikimate kinase II (AROL enzyme) can be overexpressed to increase pathway flux from DHAP to chorismate via codon optimized SEQ ID NO: 31.
- Chorismate as a general precursor compound can be converted specifically to L-tryptophan by overexpressing a series of enzymes in the L-tryptophan pathway.
- flux through the L-tryptophan pathway can be increased by overexpressing the genes that encode specific enzymes, TRP1 enzyme (as encoded by codon optimized by SEQ ID NO: 32), TRP3 enzyme (as encoded by codon optimized by SEQ ID NO: 34), and TRP4 enzyme (as encoded by codon optimized by SEQ ID NO: 35).
- TRP1 enzyme as encoded by codon optimized by SEQ ID NO: 32
- TRP3 enzyme as encoded by codon optimized by SEQ ID NO: 34
- TRP4 enzyme as encoded by codon optimized by SEQ ID NO: 35.
- overexpression of the gene that encodes the feedback-resistant mutant of TRP2 S76L enzyme (as encoded by SEQ ID NO: 33) is described herein.
- Chorismate is a precursor that feeds into the metabolic pathways that produce a variety of aromatic alcohols and aromatic amino acids.
- the mechanism made operable by systems and methods herein reduce pathway flux into pathways that produce off-pathway targets.
- the gene that encodes the native enzyme, ARO7 enzyme has been deleted to reduce production of tyrosine and phenylalanine.
- Genes that encode PDZ1 and PDZ2 enzymes have been deleted to reduce pathway flux through the pABA production pathway.
- a modified heterologous recombinant host organism is: (i) expressing endogenous pathways for L-tryptophan; (ii) expressing a recombinant version of the TAT2 L-tryptophan importer protein; and (iii) selectively expressing recombinant psilocybin biosynthetic pathway genes.
- Such a recombinant host can produce tryptamine, 4-hydroxytryptamine, norbaeocystin, baeocystin, psilocin, and psilocybin from L-tryptophan.
- L-tryptophan can be created by the host through endogenous pathways ( FIG.
- L-tryptophan may also be fed to the recombinant host organism by media supplementation and up taken by the host expressing the recombinant TAT2 importer protein. Accordingly, contact with the L-tryptophan and the recombinant host organism in the media can selectively direct flux towards psilocybin.
- Other carbon sources can make contact with the recombinant host organism in the media, wherein the other carbon sources include at least one of: glucose, galactose, sucrose, corn steep liquor, ethanol, fructose, and molasses.
- the nucleotide and amino acid sequences provided are in the order of the psilocybin pathway: PsiD, PsiH, PsiK, and PsiM genes which encode for the respective enzymes.
- PsiD enzyme selectively and cleanly catalyzes decarboxylation
- the PsiH enzyme catalyzes selective hydroxylation at the 4-position of an indole
- the PsiK enzyme catalyzes selective phosphorylation at the hydroxylated 4-position of an indole
- the PsiM enzyme catalyzes selective and stepwise methylations of an amine group, respectively.
- codon optimized nucleic acid sequences SEQ ID NO: 1, SEQ ID NO: 2, and SEQ ID NO: 3 encode for isolated amino acid sequences SEQ ID NO: 14, SEQ ID NO: 15, and SEQ ID NO: 16, respectively.
- decarboxylations would require harsh and toxic tin hydrides (e.g., Barton Decarboxylation), as opposed to the selective and clean decarboxylation by the PsiD enzyme in the recombinant host.
- codon optimized nucleic acid sequences SEQ ID NO: 4, SEQ ID NO: 5, and SEQ ID NO: 6 encode for isolated amino acid sequences SEQ ID NO: 17, SEQ ID NO: 18, and SEQ ID NO: 19, respectively.
- Phenyl group functionalization is often done at high temperatures and pressures, while leading to a mixture of products (e.g., hydroxylations at the 5, 6, and 7 positions of the indole).
- the regioisomers of the hydroxylated products at the 5, 6, and 7 positions of the indole are structurally distinct from each other, but also structurally similar to each other.
- the PsiH enzyme catalyzes selective hydroxylation of indole at the 4-position in the recombinant host organism herein at standard room conditions ( ⁇ 25 degrees Celsius at ⁇ 1 atm of atmospheric pressure).
- the systems and methods herein can produce and increase the titers of the hydroxylated indole at the 4-position within the recombinant organism.
- a sample can be obtained, which exclusively contains the hydroxylated indole at the 4-position. This is indicative of a more facile procedure for obtaining the hydroxylated indole at the 4-position, in comparison to the techniques of organic chemistry.
- codon optimized nucleic acid sequences SEQ ID NO: 7 and SEQ ID NO: 8 encode for isolated amino acid sequences SEQ ID NO: 20 and SEQ ID NO: 21, respectively.
- Primary amines and indole nitrogen are nucleophilic groups than can compete with phenolic oxygen for phosphorylation.
- the recombinant host supports the PsiK enzyme catalysis of selective phosphorylation of the phenolic oxygen.
- the recombinant host and the PsiK enzyme can also catalyze the undoing of de-phosphorylations that yield psilocin.
- the recombinant host organism and the expressed PsiK gene for encoding the PsiK enzyme can convert psilocin back to the target molecule psilocybin.
- the recombinant host organism and the expressed PsiK gene for encoding the PsiK enzyme can provide a corrective mechanism to obtain the target molecule psilocybin.
- codon optimized nucleic acid sequences SEQ ID NO: 9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO: 12, and SEQ ID NO: 13 encode for isolated amino acid sequences SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 25, and SEQ ID NO: 26, respectively.
- the primary amine when subjected to methyl iodide may get over alkylated to the quaternary amine. Further, the reaction is not selective as monoalklyated and dialkylated products may also be obtained. To further complicate the alkylation, the nitrogen of the indole is sufficiently nucleophilic to perform alkylations.
- the PsiM enzyme catalyzes selective methylation at the primary amine in the recombinant host organism, which is also stepwise.
- the first methylation yields norbaeocystin and the second methylation yields psilocybin.
- the indole nitrogen does not get methylated.
- SEQ ID NO: 1-SEQ ID NO: 36 of the systems and methods herein aid in increasing titers of psilocybin in the recombinant host organism in comparison to the titers of psilocybin in natural state of the host organism.
- the mutations at specific points of the pathways above direct flux toward yielding psilocybin in the recombinant host organism.
- genetically engineered host cells may be any species of yeast herein, including but not limited to any species of Saccharomyces, Candida, Schizosaccharomyces, Yarrowia , etc., which have been genetically altered to produce precursor molecules, intermediate molecules, and psilocybin molecules. Additionally, genetically engineered host cells may be any species of filamentous fungus, including but not limited to any species of Aspergillus , which have been genetically altered to produce precursor molecules, intermediate molecules, and psilocybin molecules.
- yeast herein for the recombinant host organism include but are not limited to: Schizosaccharomyces cerevisiae, Schizosaccharomyces japonicus, Schizosaccharomyces pombe, Schizosaccharomyces cryophilus, Saccharomyces cerevisiae, Kluyveromyces lactis, Kluyveromyces dobzhanskii , and Yarrowia lipolytica.
- the gene sequences from gene source organisms are codon optimized to improve expression using techniques disclosed in U.S. patent application Ser. No. 15/719,430, filed Sep. 28, 2017, entitled “An Isolated Codon Optimized Nucleic Acid”.
- the gene source organisms can include, but are not limited to: Psilocybe cubensis, Psilocybe cyanescens, Panaeolus cynascens, Gymnopilus junonius , and Gymnopilus dilepis .
- DNA sequences are synthesized and cloned using techniques known in the art. Gene expression can be controlled by inducible or constitutive promoter systems using the appropriate expression vectors.
- Genes are transformed into an organism using standard yeast or fungus transformation methods to generate modified host strains (i.e., the recombinant host organism).
- the modified strains express genes for: (i) producing L-tryptophan and precursor molecules to L-tryptophan; (ii) increasing an output of L-tryptophan molecules and precursor molecules to L-tryptophan molecules; (iii) increasing the import of exogenous L-tryptophan into the host strain; and (iv) the genes for the psilocybin biosynthetic pathway.
- fermentations are run to determine if the cell will convert the L-tryptophan into psilocybin.
- the L-tryptophan and psilocybin pathway genes herein can be integrated into the genome of the cell or maintained as an episomal plasmid.
- Samples are: (i) prepared and extracted using a combination of fermentation, dissolution, and purification steps; and (ii) analyzed by HPLC for the presence of precursor molecules, intermediate molecules, and psilocybin molecules.
- the genes which can be expressed to encode for a corresponding enzyme or other type of proteins include but are not limited to: PsiM, PsiH, PsiD, PsiK, TRP1, TRP2 S76L, TRP3, TRP4, ARO1, ARO2, ARO3, ARO4 K229L, and AROL.
- the PsiM gene is expressed or (overexpressed) to encode for the PsiM enzyme; the PsiH gene is overexpressed to encode for the PsiH enzyme; and so forth.
- PsiM, PsiH, PsiD, and PsiK genes can derive from: Psilocybe cubensis, Psilocybe cyanescens, Panaeolus cynascens, Gymnopilus junonius , and Gymnopilus dilepis .
- TRP1, TRP2 S76L, TRP3, TRP4, AR01, ARO2, ARO3, and ARO4 K229L genes can derive from Saccharomyces cerevisiae .
- These AROL genes can derive from Escherichia coli .
- genes are transformed into Schizosaccharomyces cerevisiae, Schizosaccharomyces japonicus, Schizosaccharomyces pombe, Schizosaccharomyces cryophilus, Saccharomyces cerevisiae, Kluyveromyces lactis, Kluyveromyces dobzhanskii , and Yarrowia lipolytica .
- the PsiM, PsiH, PsiD, PsiK, TRP1, TRP2 S76L, TRP3, TRP4, ARO1, ARO2, ARO3, ARO4 K229L, and AROL genes which derive from at least one of: Psilocybe cubensis, Psilocybe cyanescens, Panaeolus cynascens, Gymnopilus junonius, Gymnopilus dilepis, Saccharomyces cerevisiae , and Escherichia coli can be expressed at the same time. Gene sequences can be determined using the techniques disclosed in U.S. Nonprovisional patent application Ser. No. 16/558,909 filed on Sep. 3, 2019, entitled “Automated Pipeline”.
- Example 1 Construction of Saccharomyces cerevisiae Platform Strains with Elevated Metabolic Flux Towards L-Tryptophan Via Overexpression of the Feedback Resistant Mutant, ARO4 K229L
- the optimized ARO4 K229L gene is synthesized using DNA synthesis techniques known in the art.
- the optimized gene can be cloned into vectors with the proper regulatory elements for gene expression (e.g. promoter, terminator) and the derived plasmid can be confirmed by DNA sequencing.
- the optimized ARO4 K229L gene is inserted into the recombinant host genome. Integration is achieved by a single cross-over insertion event of the plasmid. Strains with the integrated gene can be screened by rescue of auxotrophy and genome sequencing.
- PDC5 Deletion of PDC5 is performed by replacement of the PDC5 gene with the URA3 cassette in the recombinant host.
- the PDC5 URA3 knockout fragment, carrying the marker cassette, URA3, and homologous sequence to the targeted gene, PDC5, can be generated by bipartite PCR amplification.
- the PCR product is transformed into a recombinant host and transformants can be selected on synthetic URA drop-out media. Further verification of the modification in said strain can be carried out by genome sequencing, and analyzed by the techniques disclosed in U.S. Nonprovisional patent application Ser. No. 16/558,909 filed on Sep. 3, 2019, entitled “Automated Pipeline”.
- Modified host cells that yield recombinant host cells express engineered psilocybin biosynthesis genes and enzymes. More specifically, the psilocybin-producing strain herein is grown in rich culture media containing yeast extract, peptone and a carbon source of glucose, galactose, sucrose, fructose, corn syrup, corn steep liquor, ethanol, and/or molasses. The recombinant host cells are grown in either shake flasks or fed-batch bioreactors. Fermentation temperatures can range from 25 degrees Celsius to 37 degrees Celsius at a pH range from pH 4 to pH 7.5.
- Exogenous L-tryptophan can be added to media to supplement the precursor pool for psilocybin production, which can be up taken by strains expressing the TAT2 L-tryptophan importer protein.
- the strains herein can be harvested during a fermentation period ranging from 12 hours onward from the start of fermentation.
- an Agilent 1100 series liquid chromatography (LC) system equipped with a HILIC column (Obelisc N, SIELC, Wheeling, Ill. USA) is used.
- a gradient is used of mobile phase A (ultraviolet (UV) grade H 2 O+0.1% Formic Acid) and mobile phase B (UV grade acetonitrile+0.1% Formic Acid).
- UV ultraviolet
- B UV grade acetonitrile+0.1% Formic Acid
- Compound absorbance is measured at 220 nanometers (nm) and 270 nm wavelength using a diode array detector (DAD) and spectral analysis from 200 nm to 400 nm wavelengths.
- a 0.1 milligram (mg)/milliliter (mL) analytical standard is made from psilocybin certified reference material (Cayman Chemical Company, USA). Each sample is prepared by diluting fermentation biomass from a recombinant host expressing the engineered psilocybin biosynthesis pathway 1:1 in 100% ethanol and filtered in 0.2 um nanofilter vials. Samples are compared to the psilocybin analytical standard retention time and UV-visible spectra for identification. As depicted in inset A of FIG.
- a fermentation derived product is obtained which has absorption of 300 au at 220 nm with a retention time of 4.55 minutes in a HPLC chromatogram.
- the fermentation derived product obtained matches the retention time of the psilocybin analytical standard in the overlaid HPLC chromatograms. This indicates that the fermentation derived product is psilocybin.
- the UV-visible spectra of the fermentation derived product and the psilocybin analytical standard are identical. This further corroborates that the fermentation derived product is psilocybin.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Botany (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
- This application claims priority from U.S. Provisional Application Ser. No. 62/936,387 filed on Nov. 15, 2019, which is incorporated herein by reference in its entirety.
- Not Applicable.
- The Sequence Listing, which is a part of the present disclosure, includes a computer readable form and a written sequence listing comprising nucleotide and/or amino acid sequences of the present invention. The sequence listing information recorded in computer readable form is identical to the written sequence listing. The ASCII text file, entitled “psilocybinseq.text”, was created on Nov. 15, 2019 using PatentIn version 3.5 and is incorporated herein by reference in its entirety. The subject matter of the Sequence Listing is incorporated herein by reference in its entirety.
- The present invention generally relates to the production of psilocybin and its intermediates (e.g., tryptamine, 4-hydroxytryptamine, norbaeocystin, baeocystin, and psilocin) in a modified heterologous microorganism.
- Mental health problems, which may also be referred to as mental illness or psychiatric disorder, are behavioral or mental patterns which impair the functioning of individuals across the world. Psilocybin has been increasingly evaluated for treating mental health problems. Such mental health disorders include: personality disorders, anxiety disorders, major depressions, and various addictions. In contrast to anxiolytic medicines, usage of psilocybin does not lead to physical dependence.
- The present teachings include a recombinant host organism. The recombinant host organism can include: a plurality of cells transfected by a set of genes for synthesizing psilocybin in the recombinant host organism via at least a first pathway and a second pathway. The recombinant host organism can be a fungal species comprising: Schizosaccharomyces cerevisiae, Schizosaccharomyces japonicus, Schizosaccharomyces pombe, Schizosaccharomyces cryophilus, Saccharomyces cerevisiae, Kluyveromyces lactis, Kluyveromyces dobzhanskii, and Yarrowia lipolytica. The set of genes can include any combination of a gene selected from a group consisting of PsiD, PsiH, PsiK, and PsiM.
- In accordance with a further aspect, PsiD can comprise codon optimized nucleic acid sequences SEQ ID NO: 1, SEQ ID NO: 2, and SEQ ID NO: 3 that encode for isolated amino acid sequences SEQ ID NO: 14, SEQ ID NO: 15, and SEQ ID NO: 16, respectively; PsiH can comprise codon optimized nucleic acid sequences SEQ ID NO: 4, SEQ ID NO: 5, and SEQ ID NO: 6 that encode for isolated amino acid sequences SEQ ID NO: 17 SEQ ID NO: 18, and SEQ ID NO: 19, respectively; PsiK can comprise codon optimized nucleic acid sequences SEQ ID NO: 7 and SEQ ID NO: 8 that encode for isolated amino acid sequences SEQ ID NO: 20 and SEQ ID NO: 21, respectively; and PsiM can comprises codon optimized nucleic acid sequences SEQ ID NO: 9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO: 12, and SEQ ID NO: 13 that encode for isolated amino acid sequences SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24; SEQ ID NO: 25, and SEQ ID NO: 26, respectively.
- In accordance with a further aspect, the set of genes can express amino acid sequences that increase titers of psilocybin in the plurality of cells.
- In accordance with a further aspect, the set of genes can synthesize intermediates of psilocybin, wherein the intermediates comprise: tryptamine, 4-hydroxytryptamine, norbaeocystin, baeocystin, and psilocin.
- In accordance with a further aspect, a protein can be heterologous to the plurality of cells and an exogenous substrate, wherein the protein is encoded by codon optimized SEQ ID NO: 36.
- In accordance with a further aspect, the carbon source can include at least one of: glucose, galactose, sucrose, fructose, corn syrup, corn steep liquor, ethanol, and molasses.
- In accordance with another aspect, the first pathway can be a shikimate-chorismate pathway and the second pathway can be a L-tryptophan pathway
- In accordance with another aspect, the first pathway can be modified by codon optimized SEQ ID NO: 27, SEQ ID NO. 28, SEQ ID NO: 29, SEQ ID NO: 30, and SEQ ID NO: 31 and the second pathway is modified by codon optimized SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO: 34, and SEQ ID NO: 35.
- The present teaching include a plurality of sequences containing nucleotides or amino acids for producing psilocybin in a recombinant host organism, wherein the plurality of sequences comprise SEQ ID NO: 1-SEQ ID NO: 36.
- In accordance with a further aspect, an isolated amino acid sequence comprises SEQ ID NO: 14, SEQ ID NO: 15, and SEQ ID NO: 16, wherein SEQ ID NO: 14, SEQ ID NO: 15, and SEQ ID NO: 16 can be at least 50% similar to each other, and wherein SEQ ID NO: 14 is encoded by codon optimized SEQ ID NO: 1, SEQ ID NO: 15 is encoded by codon optimized SEQ ID NO: 2, and SEQ ID NO: 16 is encoded by codon optimized SEQ ID NO: 3.
- In accordance with a further aspect, an isolated amino acid sequence comprises at least one of: SEQ ID NO: 17, SEQ ID NO: 18, and SEQ ID NO: 19, wherein SEQ ID NO: 17, SEQ ID NO: 18, and SEQ ID NO: 19 are at least 40% similar to each other, and wherein SEQ ID NO: 17 is encoded by codon optimized SEQ ID NO: 4, SEQ ID NO: 18 is encoded by codon optimized SEQ ID NO: 5, and SEQ ID NO: 19 is encoded by codon optimized SEQ ID NO: 6.
- In accordance with a further aspect, an isolated amino acid sequence comprises at least one of: SEQ ID NO: 20 and SEQ ID NO: 21, wherein SEQ ID NO: 20 and SEQ ID NO: 21 are at least 85% similar to each other; and wherein SEQ ID NO: 21 is encoded by codon optimized SEQ ID NO: 7 and SEQ ID NO: 22 is encoded by codon optimized SEQ ID NO: 8.
- In accordance with a further aspect, an isolated amino acid sequence comprises at least one of: SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 25, and SEQ ID NO: 26, wherein SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 25, and SEQ ID NO: 26 are at least 55% similar to each other, and wherein SEQ ID NO: 22 is encoded by codon optimized SEQ ID NO: 9, SEQ ID NO: 23 is encoded by codon optimized SEQ ID NO: 10, SEQ ID NO: 24 is encoded by SEQ ID NO: 11, SEQ ID NO: 25 is encoded by SEQ ID NO: 12, and SEQ ID NO: 26 is encoded by SEQ ID NO: 13.
- The present teachings include a method. The method can include: transfecting a plurality of cells in a recombinant host organism a set of genes for synthesizing psilocybin via at least a first pathway and a second pathway; and increasing titers of psilocybin in the plurality of cells via the set of genes; and synthesizing intermediates of psilocybin via the set of genes. The recombinant host organism can be a fungal species comprising: Schizosaccharomyces cerevisiae, Schizosaccharomyces japonicus, Schizosaccharomyces pombe, Schizosaccharomyces cryophilus, Saccharomyces cerevisiae, Kluyveromyces lactis, Kluyveromyces dobzhanskii, and Yarrowia lipolytica. The The set of genes can include a gene from a group consisting of: PsiD, PsiH, PsiK, and PsiM.
- In accordance with a further aspect, PsiD can comprise codon optimized nucleic acid sequences SEQ ID NO: 1, SEQ ID NO: 2, and SEQ ID NO: 3 that encode for isolated amino acid sequences SEQ ID NO: 14, SEQ ID NO: 15, and SEQ ID NO: 16, respectively; wherein PsiH can comprise codon optimized nucleic acid sequences SEQ ID NO: 4, SEQ ID NO: 5, and SEQ ID NO: 6 that encode for isolated amino acid sequences SEQ ID NO: 17, SEQ ID NO: 18, and SEQ ID NO: 19, respectively; wherein PsiK can comprise codon optimized nucleic acid sequences SEQ ID NO: 7 and SEQ ID NO: 8 that encode for isolated amino acid sequences SEQ ID NO: 20 and SEQ ID NO: 21, respectively; and wherein PsiM can comprise codon optimized nucleic acid sequences SEQ ID NO: 9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO: 12, and SEQ ID NO: 13 that encode for isolated amino acid sequences SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24; SEQ ID NO: 25, and SEQ ID NO: 26, respectively.
- In accordance with a further aspect, the carbon source can include at least one of: glucose, galactose, sucrose, fructose, corn syrup, corn steep liquor, ethanol, and molasses.
- In accordance with a further aspect, the method can also include an exogenous substrate and a transporter protein.
- In accordance with a further aspect, the first pathway can be a shikimate-chorismate pathway modified by codon optimized SEQ ID NO: 27, SEQ ID NO. 28, SEQ ID NO: 29, SEQ ID NO: 30, and SEQ ID NO: 31 and the second pathway can be a L-tryptophan pathway modified by codon optimized SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO: 34, and SEQ ID NO: 35.
- In accordance with a further aspect, the transporter protein can be encoded by codon optimized SEQ ID NO: 36.
- In accordance with a further aspect, the intermediates can include: tryptamine, 4-hydroxytryptamine, norbaeocystin, baeocystin, and psilocin.
- These and other features, aspects, and advantages of the present teachings will become better understood with reference to the following description, examples and appended claims.
- Those of skill in the art will understand that the drawings, described below, are for illustrative purposes only. The drawings are not intended to limit the scope of the present teachings in any way.
-
FIG. 1 depicts a table of amino acids and codon triplets. -
FIG. 2 depicts a table of genes and enzymes inserted into a recombinant host organism. -
FIG. 3 depicts the biosynthesis of psilocybin. -
FIG. 4-7 depicts sequence alignments. -
FIG. 8 depicts endogenous pathways in a host organism. -
FIG. 9 depicts a scheme to increase metabolic flux through shikimate-chorismate and L-tryptophan pathways. -
FIG. 10 depicts a heterologous recombinant host organism. -
FIG. 11 depicts HPLC chromatograms and UV/Vis spectra. - To facilitate understanding of the invention, a number of terms and abbreviations as used herein are defined below as follows:
- Amino acids: As used herein, the term “amino acids” refer to the molecular basis for constructing and assembling proteins, such as enzymes. (See
FIG. 1 for a table of amino acids.). Peptide bonds (i.e., polypeptides) are formed between amino acids and assemble three-dimensionally (3-D). The 3-D assembly can influence the properties, function, and conformational dynamics of the protein. Within biological systems, the protein may: (i) catalyze reactions as enzymes; (ii) transport vesicles, molecules, and other entities within cells as transporter entities; (iii) provide structure to cells and organisms as protein filaments; (iv) replicate deoxyribonucleic acid (DNA); and (v) coordinate actions of cells as cell signalers. - Nucleotides: As used herein, the term “nucleotides” refers to the molecular basis for constructing and assembling nucleic acids, such as DNA and ribonucleic acid (RNA). There are two types of nucleotides—purines and pyrimidines. The specific purines are adenine (A) and guanine (G). The specific pyrimidines are cytosine (C), uracil (U), and thymine (T). T is found in DNA, whereas U is found in RNA. The genetic code defines the sequence of nucleotide triplets (i.e., codons) for specifying which amino acids are added during protein synthesis.
- Genes: As used herein, the term “genes” refers to regions of DNA. Amino acid sequences in the proteins, as defined by the sequence of a gene, are encoded in the genetic code.
- The present invention is directed to biosynthetic production of psilocybin and related intermediates in recombinant organisms. The syntheses of psilocybin and intermediates of psilocybin in a laboratory environment typically involve tedious techniques of organic chemistry. Often reproducibility is elusive and the solvents used during the syntheses of psilocybin and intermediates of psilocybin are environmentally toxic. Decarboxylations, selective methylations, and selective phosphorylations can be difficult to obtain via the techniques of organic chemistry. Further, the yields and purity of the intermediates for obtaining the target molecules can be low using the techniques of organic chemistry, where the starting molecule is L-tryptophan and the target molecule is psilocybin.
- The systems and method herein disclose more environmentally benign processes which can have higher throughputs (i.e., more robust processes). The systems and methods herein include: (i) growing modified recombinant host cells and thereby yielding a recombinant host organism; (ii) expressing engineered psilocybin biosynthesis genes and enzymes in the recombinant host organism; (iii) producing or synthesizing psilocybin and/or intermediates of psilocybin in the recombinant host organism; (iv) fermenting the recombinant host organism; and (v) isolating the psilocybin and/or intermediates of psilocybin from the recombinant host organism. Endogenous pathways of the recombinant host can be modified by the systems and methods herein to produce high purity psilocybin and/or intermediates of psilocybin.
- Reference is made to the figures to further describe the systems and methods disclosed herein.
- Referring to
FIG. 2 , a table lists the enzymes involved in the direct biosynthesis of psilocybin and psilocybin intermediates in species of fungus (i.e., mushrooms). Gene source organisms provide a genetic starting source (i.e., raw gene sequences) which is codon optimized and engineered to function in the recombinant host organisms. The recombinant host organisms include but are not limited to: Schizosaccharomyces cerevisiae, Schizosaccharomyces japonicus, Schizosaccharomyces pombe, Schizosaccharomyces cryophilus, Saccharomyces cerevisiae, Kluyveromyces lactis, Kluyveromyces dobzhanskii, and Yarrowia lipolytica. - Further, the genes/enzymes that are inserted or engineered into the recombinant host are PsiD, PsiH, PsiK, and PsiM.
- A PsiD enzyme, which is a decarboxylase (e.g., L-tryptophan decarboxylase) derives from a gene source organism herein—Psilocybe cubensis, Psilocybe cyanescens, and Gymnopilus junonius. The decarboxylase can catalyze the decarboxylation of an aliphatic carboxylic acid (i.e., release carbon dioxide) L-tryptophan to tryptamine and 4-hydroxy-L-tryptophan to 4-hydroxytryptamine, as depicted in
FIG. 3 . - A PsiH enzyme, which is a monooxygenase (e.g., Tryptamine 4-monooxygenase) derives from a gene source organism herein—Psilocybe cubensis, Psilocybe cyanescens, and Gymnopilus junonius. The monooxygenase can catalyze the oxidative hydroxylation of the phenyl ring of tryptamine to 4-hydroxytryptamine, as depicted in
FIG. 3 . - A PsiK enzyme, which is a kinase (e.g., 4-hydroxytryptamine kinase) derives from a gene source organism herein—Psilocybe cubensis and Psilocybe cyanescens. The kinase can catalyze the phosphorylation (i.e., adding O═P(OH)2) of the phenolic oxygen of 4-hydroxytryptamine to norbaeocystin, as depicted in
FIG. 3 . The kinase can also catalyze the phosphorylation of psilocin to psilocybin. - A PsiM enzyme, which is a methyl transferase (e.g., psilocybin synthase) derives from a gene source organism herein—Psilocybe cubensis, Psilocybe cyanescens, Panaeolus cynascens, Gymnopilus junonius, and Gymnopilus dilepis. The methyl transferase can catalyze the alkylation (i.e., adding a methyl (CH3) group) of the primary amine in norbaeocystin to baecystin, as depicted in
FIG. 3 . Another alkylation can take place where the methyl transferase when the secondary amine of baecystin becomes a tertiary amine of psilocybin, as depicted inFIG. 3 . - As depicted in
FIG. 3 , the engineered PsiD, PsiH, PsiK, and PsiM enzymes act on substrates in the psilocybin biosynthetic pathway to produce intermediates of psilocybin and psilocybin itself. The initial substrate for psilocybin intermediates and psilocybin can be L-tryptophan and/or 4-hydroxy-L-tryptophan. These initial substrates can be produced endogenously in a recombinant host as described and/or provided exogenously to a fermentation involving a recombinant host, whereby the host uptakes the starting substrates to feed into the psilocybin biosynthetic pathway. The recombinant host herein described that is expressing all, one, or multiple combinations of the engineered PsiD, PsiH, PsiK, PsiM genes can produce tryptamine, 4-hydroxytryptamine, norbaeocystin, baeocystin, psilocybin, and psilocin. Psilocybin may be converted to psilocin due to spontaneous dephosphorylation. Psilocin is in turn an intermediate which can be acted on by the PsiK enzyme to produce psilocybin. - As depicted in
FIG. 4 , the amino acid alignments of recombinant PsiD enzymes are presented. Recombinant PsiD enzymes have been reengineered from various fungal species to function in heterologous recombinant host organisms herein. The gene used in the pair wise alignment is the PsiD gene from the fungal species—Psilocybe cubensis, Psilocybe cyanescens, and Gymnopilus junonius. The alignment is performed with EMBOSS Needle Pair wise Sequence Alignment statistic (EBLOSUM62) with Psilocybe cubensis (PsiD gene) as a reference. The identity percentage and similarity percentage of the amino acid sequences are presented. - For the PsiD gene, codon optimized nucleic acid sequences SEQ ID NO: 1, SEQ ID NO: 2, and SEQ ID NO: 3 encode for isolated amino acid sequences SEQ ID NO: 14, SEQ ID NO: 15, and SEQ ID NO: 16, respectively. SEQ ID NO: 14 is Psilocybe cubensis (PsiD gene); SEQ ID NO: 15 is Psilocybe cyanescens (PsiD gene); and SEQ ID NO: 16 is Gymnopilus junonius (PsiD gene).
- As depicted in
FIG. 5 , the amino acid alignment of recombinant PsiH enzymes are presented. Recombinant PsiH enzymes have been reengineered from various fungal species to function in heterologous recombinant host organisms herein. The gene used in the pair wise alignment is the PsiH gene from the fungal species—Psilocybe cubensis, Psilocybe cyanescens, and Gymnopilus junonius. The alignment is performed with EMBOSS Needle Pair wise Sequence Alignment statistic (EBLOSUM62) with Psilocybe cubensis (PsiH gene) as a reference. The identity percentage and similarity percentage of the amino acid sequences are presented. - For the PsiH gene, codon optimized nucleic acid sequences SEQ ID NO: 4, SEQ ID NO: 5, and SEQ ID NO: 6 encode for isolated amino acid sequences SEQ ID NO: 17 SEQ ID NO: 18, and SEQ ID NO: 19, respectively. SEQ ID NO: 17 is Psilocybe cubensis (PsiH gene); SEQ ID NO: 18 is Psilocybe cyanescens (PsiH gene); and SEQ ID NO: 19 is Gymnopilus junonius (PsiH gene).
- As depicted in
FIG. 6 , the amino acid alignment of recombinant PsiK enzymes are presented. Recombinant PsiK enzymes have been reengineered from various fungal species to function in heterologous recombinant host organisms herein. The gene used in the pair wise alignment is the PsiK gene from the fungal species—Psilocybe cubensis and Psilocybe cyanescens. The alignment is performed with EMBOSS Needle Pair wise Sequence Alignment statistic (EBLOSUM62) with Psilocybe cubensis (PsiK gene) as a reference. The identity percentage and similarity percentage of the amino acid sequences are presented. - For the PsiK gene, codon optimized nucleic acid sequences SEQ ID NO: 7 and SEQ ID NO: 8 encode for isolated amino acid sequences SEQ ID NO: 20 and SEQ ID NO: 21, respectively. SEQ ID NO: 20 is Psilocybe cubensis (PsiK gene) and SEQ ID NO: 21 is Psilocybe cyanescens (PsiK gene).
- As depicted in
FIG. 7 , the amino acid alignment of recombinant PsiM enzymes are presented. Recombinant PsiM enzymes have been reengineered from various fungal species to function in heterologous recombinant host organisms herein. The gene used in the pair wise alignment is the PsiM gene from the fungal species—Psilocybe cubensis, Psilocybe cyanescens, Panaeolus cynascens, Gymnopilus junonius, and Gymnopilus dilepis. The alignment is performed with EMBOSS Needle Pair wise Sequence Alignment statistic (EBLOSUM62) with Psilocybe cubensis (PsiM gene) as a reference. The identity percentage and similarity percentage of the amino acid sequences are presented. - For the PsiM gene, codon optimized nucleic acid sequences SEQ ID NO: 9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO: 12, and SEQ ID NO: 13 encode for isolated amino acid sequences SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24; SEQ ID NO: 25, and SEQ ID NO: 26, respectively. SEQ ID NO: 22 is Psilocybe cubensis (PsiM gene); SEQ ID NO: 23 is Psilocybe cyanescens (PsiM gene); SEQ ID NO: 24 is Panaeolus cynascens (PsiM gene); SEQ ID NO: 25 is Gymnopilus junonius (PsiM gene), and SEQ ID NO: 26 is Gymnopilus dilepis (PsiM gene).
- As depicted in
FIG. 8 , the endogenous pathways of a recombinant host organism produce precursors for the engineered PsiD, PsiH, PsiK, PsiM genes. Pathways relating to chorismate, L-glutamine, and L-serine, feed into the endogenous pathway for L-tryptophan production, which a recombinant host organism expressing the psilocybin biosynthetic pathway herein described can use to create tryptamine, 4-hydroxytryptamine, norbaeocystin, baeocystin, psilocin, and psilocybin. The enzymes in the endogenous pathways of the recombinant host organism are encircled inFIG. 8 . Glycolysis and gluconeogenesis in combination with ARO3, ARO4, ARO1, and ARO2 enzymes can be subjected to the depicted precursors at the specified point in the pathway to selectively yield chrorismate. The glutamate biosynthesis pathway in combination with a GLN1 enzyme can be subjected to the depicted precursor at the specified point in the pathway to selectively yield L-glutamine. Glycolysis in combination with SER3, SER33, SER1, and SER2 enzymes can be subjected to the depicted precursors at the specified points in the pathway to selectively yield L-serine. Chorismate and L-glutamine in combination with TRP1, TRP2, TRP3, and TRP4 enzymes can be subjected to the depicted precursors at the specified point to selectively yield (1S,2R)-1-C-indol-3-yl)glycerol 3-phosphate. The addition of L-serine to (1S,2R)-1-C-indol-3-yl)glycerol 3-phosphate in the presence of the TRP1 enzyme can yield L-tryptophan. - As depicted in
FIG. 9 , a scheme to increase metabolic flux through the shikimate-chorismate and L-tryptophan pathways is disclosed. The increased metabolic flux through the shikimate-chorismate and L-tryptophan pathways increases the production of L-tryptophan, a key precursor compound for the production of psilocybin and intermediates of psilocybin. Specific enzymes in the described native pathways are overexpressed. Enzymes subject to allosteric inhibition are mutated and overexpressed to render the enzymes insensitive to feedback mechanisms. Enzymes that consume pathway intermediates for off-pathway compound production are hereby deleted. - L-tryptophan production is improved herein by overexpressing a series of enzymes that first increase production of the aromatic compound intermediate, chorismate in a series of enzymatic reactions known as the shikimate pathway. As described in
FIG. 5 , the shikimate-chorismate pathway initial precursors, PEP and E4P are converted into 3-deoxy-D-arabinoheptulosonate 7-phosphate (DAHP), catalyzed by ARO3 and ARO4 enzymes. - Overexpression of the genes encoding ARO3 enzyme (as encoded by codon optimized SEQ ID NO: 29), and a feedback-resistant mutant ARO4 K229L enzyme (as encoded by codon optimized SEQ ID NO: 30) are described herein and can increase metabolic flux through the pathway. In addition, genes that encode key enzymes, ARO1 enzyme (as encoded by codon optimized SEQ ID NO: 27) and ARO2 (as encoded by codon optimized SEQ ID NO: 28) are overexpressed as part of a series of enzymes that can convert DAHP to chorismate. In addition, the gene that encodes the Escherichia coli shikimate kinase II (AROL enzyme) can be overexpressed to increase pathway flux from DHAP to chorismate via codon optimized SEQ ID NO: 31.
- Chorismate as a general precursor compound can be converted specifically to L-tryptophan by overexpressing a series of enzymes in the L-tryptophan pathway. As described in
FIG. 9 , flux through the L-tryptophan pathway can be increased by overexpressing the genes that encode specific enzymes, TRP1 enzyme (as encoded by codon optimized by SEQ ID NO: 32), TRP3 enzyme (as encoded by codon optimized by SEQ ID NO: 34), and TRP4 enzyme (as encoded by codon optimized by SEQ ID NO: 35). Furthermore, overexpression of the gene that encodes the feedback-resistant mutant of TRP2 S76L enzyme (as encoded by SEQ ID NO: 33) is described herein. - Chorismate is a precursor that feeds into the metabolic pathways that produce a variety of aromatic alcohols and aromatic amino acids. The mechanism made operable by systems and methods herein reduce pathway flux into pathways that produce off-pathway targets. As described in
FIG. 9 , genes that encode native enzymes—PDC5 enzyme and ARO10 enzyme—have been deleted to reduce pathway flux through the pathways that produce aromatic alcohols. The gene that encodes the native enzyme, ARO7 enzyme has been deleted to reduce production of tyrosine and phenylalanine. Genes that encode PDZ1 and PDZ2 enzymes have been deleted to reduce pathway flux through the pABA production pathway. - As depicted in
FIG. 10 , a modified heterologous recombinant host organism is: (i) expressing endogenous pathways for L-tryptophan; (ii) expressing a recombinant version of the TAT2 L-tryptophan importer protein; and (iii) selectively expressing recombinant psilocybin biosynthetic pathway genes. Such a recombinant host can produce tryptamine, 4-hydroxytryptamine, norbaeocystin, baeocystin, psilocin, and psilocybin from L-tryptophan. L-tryptophan can be created by the host through endogenous pathways (FIG. 8 ) or engineered pathways (FIG. 9 ). L-tryptophan may also be fed to the recombinant host organism by media supplementation and up taken by the host expressing the recombinant TAT2 importer protein. Accordingly, contact with the L-tryptophan and the recombinant host organism in the media can selectively direct flux towards psilocybin. Other carbon sources can make contact with the recombinant host organism in the media, wherein the other carbon sources include at least one of: glucose, galactose, sucrose, corn steep liquor, ethanol, fructose, and molasses. - Besides the recombinant TAT2 importer protein, which is encoded by a codon optimized L-tryptophan importer (SEQ ID NO: 36), the nucleotide and amino acid sequences provided are in the order of the psilocybin pathway: PsiD, PsiH, PsiK, and PsiM genes which encode for the respective enzymes. In the systems and methods herein, PsiD enzyme selectively and cleanly catalyzes decarboxylation; the PsiH enzyme catalyzes selective hydroxylation at the 4-position of an indole; the PsiK enzyme catalyzes selective phosphorylation at the hydroxylated 4-position of an indole; and the PsiM enzyme catalyzes selective and stepwise methylations of an amine group, respectively.
- By expressing the PsiD gene in the recombinant host organism, codon optimized nucleic acid sequences SEQ ID NO: 1, SEQ ID NO: 2, and SEQ ID NO: 3 encode for isolated amino acid sequences SEQ ID NO: 14, SEQ ID NO: 15, and SEQ ID NO: 16, respectively. Using the techniques of organic chemistry, decarboxylations would require harsh and toxic tin hydrides (e.g., Barton Decarboxylation), as opposed to the selective and clean decarboxylation by the PsiD enzyme in the recombinant host.
- By expressing the PsiH gene in the recombinant host organism, codon optimized nucleic acid sequences SEQ ID NO: 4, SEQ ID NO: 5, and SEQ ID NO: 6 encode for isolated amino acid sequences SEQ ID NO: 17, SEQ ID NO: 18, and SEQ ID NO: 19, respectively. Phenyl group functionalization is often done at high temperatures and pressures, while leading to a mixture of products (e.g., hydroxylations at the 5, 6, and 7 positions of the indole). The regioisomers of the hydroxylated products at the 5, 6, and 7 positions of the indole are structurally distinct from each other, but also structurally similar to each other. Separation of such regioisomers can be very challenging and requires cumbersome separation techniques (e.g., slow column chromatography with poor separation (i.e., the regiosiomers have similar Rf values to each other) and low accompanying yields). In contrast, the PsiH enzyme catalyzes selective hydroxylation of indole at the 4-position in the recombinant host organism herein at standard room conditions (˜25 degrees Celsius at ˜1 atm of atmospheric pressure). The systems and methods herein can produce and increase the titers of the hydroxylated indole at the 4-position within the recombinant organism. Using the purification techniques, as described in more detail with respect to the Examples, a sample can be obtained, which exclusively contains the hydroxylated indole at the 4-position. This is indicative of a more facile procedure for obtaining the hydroxylated indole at the 4-position, in comparison to the techniques of organic chemistry.
- By expressing the PsiK gene in the recombinant host organism, codon optimized nucleic acid sequences SEQ ID NO: 7 and SEQ ID NO: 8 encode for isolated amino acid sequences SEQ ID NO: 20 and SEQ ID NO: 21, respectively. Primary amines and indole nitrogen are nucleophilic groups than can compete with phenolic oxygen for phosphorylation. In contrast, the recombinant host supports the PsiK enzyme catalysis of selective phosphorylation of the phenolic oxygen. The recombinant host and the PsiK enzyme can also catalyze the undoing of de-phosphorylations that yield psilocin. Stated another way, the recombinant host organism and the expressed PsiK gene for encoding the PsiK enzyme can convert psilocin back to the target molecule psilocybin. Stated yet another way, the recombinant host organism and the expressed PsiK gene for encoding the PsiK enzyme can provide a corrective mechanism to obtain the target molecule psilocybin.
- By expressing the PsiM gene in the recombinant host organism, codon optimized nucleic acid sequences SEQ ID NO: 9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO: 12, and SEQ ID NO: 13 encode for isolated amino acid sequences SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 25, and SEQ ID NO: 26, respectively. The primary amine when subjected to methyl iodide may get over alkylated to the quaternary amine. Further, the reaction is not selective as monoalklyated and dialkylated products may also be obtained. To further complicate the alkylation, the nitrogen of the indole is sufficiently nucleophilic to perform alkylations. In contrast, the PsiM enzyme catalyzes selective methylation at the primary amine in the recombinant host organism, which is also stepwise. The first methylation yields norbaeocystin and the second methylation yields psilocybin. The indole nitrogen does not get methylated.
- SEQ ID NO: 1-SEQ ID NO: 36 of the systems and methods herein aid in increasing titers of psilocybin in the recombinant host organism in comparison to the titers of psilocybin in natural state of the host organism. As described above, the mutations at specific points of the pathways above direct flux toward yielding psilocybin in the recombinant host organism.
- Aspects of the present teachings may be further understood in light of the following examples, which should not be construed as limiting the scope of the present teachings in any way.
- The following examples are provided to illustrate various aspects of the present invention. They are not intended to limit the invention, which is defined by the accompanying claims.
- In the examples below, genetically engineered host cells may be any species of yeast herein, including but not limited to any species of Saccharomyces, Candida, Schizosaccharomyces, Yarrowia, etc., which have been genetically altered to produce precursor molecules, intermediate molecules, and psilocybin molecules. Additionally, genetically engineered host cells may be any species of filamentous fungus, including but not limited to any species of Aspergillus, which have been genetically altered to produce precursor molecules, intermediate molecules, and psilocybin molecules. Some of the species of yeast herein for the recombinant host organism include but are not limited to: Schizosaccharomyces cerevisiae, Schizosaccharomyces japonicus, Schizosaccharomyces pombe, Schizosaccharomyces cryophilus, Saccharomyces cerevisiae, Kluyveromyces lactis, Kluyveromyces dobzhanskii, and Yarrowia lipolytica.
- The gene sequences from gene source organisms are codon optimized to improve expression using techniques disclosed in U.S. patent application Ser. No. 15/719,430, filed Sep. 28, 2017, entitled “An Isolated Codon Optimized Nucleic Acid”. The gene source organisms can include, but are not limited to: Psilocybe cubensis, Psilocybe cyanescens, Panaeolus cynascens, Gymnopilus junonius, and Gymnopilus dilepis. DNA sequences are synthesized and cloned using techniques known in the art. Gene expression can be controlled by inducible or constitutive promoter systems using the appropriate expression vectors. Genes are transformed into an organism using standard yeast or fungus transformation methods to generate modified host strains (i.e., the recombinant host organism). The modified strains express genes for: (i) producing L-tryptophan and precursor molecules to L-tryptophan; (ii) increasing an output of L-tryptophan molecules and precursor molecules to L-tryptophan molecules; (iii) increasing the import of exogenous L-tryptophan into the host strain; and (iv) the genes for the psilocybin biosynthetic pathway. In the presence or absence of exogenous L-tryptophan, fermentations are run to determine if the cell will convert the L-tryptophan into psilocybin. The L-tryptophan and psilocybin pathway genes herein can be integrated into the genome of the cell or maintained as an episomal plasmid. Samples are: (i) prepared and extracted using a combination of fermentation, dissolution, and purification steps; and (ii) analyzed by HPLC for the presence of precursor molecules, intermediate molecules, and psilocybin molecules.
- Using the systems and methods herein, the genes which can be expressed to encode for a corresponding enzyme or other type of proteins include but are not limited to: PsiM, PsiH, PsiD, PsiK, TRP1, TRP2 S76L, TRP3, TRP4, ARO1, ARO2, ARO3, ARO4 K229L, and AROL. For example, the PsiM gene is expressed or (overexpressed) to encode for the PsiM enzyme; the PsiH gene is overexpressed to encode for the PsiH enzyme; and so forth. These PsiM, PsiH, PsiD, and PsiK genes can derive from: Psilocybe cubensis, Psilocybe cyanescens, Panaeolus cynascens, Gymnopilus junonius, and Gymnopilus dilepis. These TRP1, TRP2 S76L, TRP3, TRP4, AR01, ARO2, ARO3, and ARO4 K229L genes can derive from Saccharomyces cerevisiae. These AROL genes can derive from Escherichia coli. Further, these genes are transformed into Schizosaccharomyces cerevisiae, Schizosaccharomyces japonicus, Schizosaccharomyces pombe, Schizosaccharomyces cryophilus, Saccharomyces cerevisiae, Kluyveromyces lactis, Kluyveromyces dobzhanskii, and Yarrowia lipolytica. The PsiM, PsiH, PsiD, PsiK, TRP1, TRP2 S76L, TRP3, TRP4, ARO1, ARO2, ARO3, ARO4 K229L, and AROL genes which derive from at least one of: Psilocybe cubensis, Psilocybe cyanescens, Panaeolus cynascens, Gymnopilus junonius, Gymnopilus dilepis, Saccharomyces cerevisiae, and Escherichia coli can be expressed at the same time. Gene sequences can be determined using the techniques disclosed in U.S. Nonprovisional patent application Ser. No. 16/558,909 filed on Sep. 3, 2019, entitled “Automated Pipeline”.
- The optimized ARO4 K229L gene is synthesized using DNA synthesis techniques known in the art. The optimized gene can be cloned into vectors with the proper regulatory elements for gene expression (e.g. promoter, terminator) and the derived plasmid can be confirmed by DNA sequencing. As an alternative to expression from an episomal plasmid, the optimized ARO4 K229L gene is inserted into the recombinant host genome. Integration is achieved by a single cross-over insertion event of the plasmid. Strains with the integrated gene can be screened by rescue of auxotrophy and genome sequencing.
- Deletion of PDC5 is performed by replacement of the PDC5 gene with the URA3 cassette in the recombinant host. The PDC5 URA3 knockout fragment, carrying the marker cassette, URA3, and homologous sequence to the targeted gene, PDC5, can be generated by bipartite PCR amplification. The PCR product is transformed into a recombinant host and transformants can be selected on synthetic URA drop-out media. Further verification of the modification in said strain can be carried out by genome sequencing, and analyzed by the techniques disclosed in U.S. Nonprovisional patent application Ser. No. 16/558,909 filed on Sep. 3, 2019, entitled “Automated Pipeline”.
- Modified host cells that yield recombinant host cells, such as the psilocybin-producing strain herein, express engineered psilocybin biosynthesis genes and enzymes. More specifically, the psilocybin-producing strain herein is grown in rich culture media containing yeast extract, peptone and a carbon source of glucose, galactose, sucrose, fructose, corn syrup, corn steep liquor, ethanol, and/or molasses. The recombinant host cells are grown in either shake flasks or fed-batch bioreactors. Fermentation temperatures can range from 25 degrees Celsius to 37 degrees Celsius at a pH range from
pH 4 to pH 7.5. Exogenous L-tryptophan can be added to media to supplement the precursor pool for psilocybin production, which can be up taken by strains expressing the TAT2 L-tryptophan importer protein. The strains herein can be harvested during a fermentation period ranging from 12 hours onward from the start of fermentation. - To identify fermentation derived psilocybin produced by a recombinant host expressing the engineered psilocybin biosynthetic pathway, an Agilent 1100 series liquid chromatography (LC) system equipped with a HILIC column (Obelisc N, SIELC, Wheeling, Ill. USA) is used. A gradient is used of mobile phase A (ultraviolet (UV) grade H2O+0.1% Formic Acid) and mobile phase B (UV grade acetonitrile+0.1% Formic Acid). Column temperature is set at 40 degree Celsius. Compound absorbance is measured at 220 nanometers (nm) and 270 nm wavelength using a diode array detector (DAD) and spectral analysis from 200 nm to 400 nm wavelengths. A 0.1 milligram (mg)/milliliter (mL) analytical standard is made from psilocybin certified reference material (Cayman Chemical Company, USA). Each sample is prepared by diluting fermentation biomass from a recombinant host expressing the engineered psilocybin biosynthesis pathway 1:1 in 100% ethanol and filtered in 0.2 um nanofilter vials. Samples are compared to the psilocybin analytical standard retention time and UV-visible spectra for identification. As depicted in inset A of
FIG. 11 , a fermentation derived product is obtained which has absorption of 300 au at 220 nm with a retention time of 4.55 minutes in a HPLC chromatogram. As depicted in inset B ofFIG. 11 , the fermentation derived product obtained matches the retention time of the psilocybin analytical standard in the overlaid HPLC chromatograms. This indicates that the fermentation derived product is psilocybin. As depicted in inset C ofFIG. 11 , the UV-visible spectra of the fermentation derived product and the psilocybin analytical standard are identical. This further corroborates that the fermentation derived product is psilocybin. - The detailed description set-forth above is provided to aid those skilled in the art in practicing the present invention. However, the invention described and claimed herein is not to be limited in scope by the specific embodiments herein disclosed because these embodiments are intended as illustration of several aspects of the invention. Any equivalent embodiments are intended to be within the scope of this invention. Indeed, various modifications of the invention in addition to those shown and described herein will become apparent to those skilled in the art from the foregoing description which does not depart from the spirit or scope of the present inventive discovery. Such modifications are also intended to fall within the scope of the appended claims.
- All publications, patents, patent applications and other references cited in this application are incorporated herein by reference in their entirety for all purposes to the same extent as if each individual publication, patent, patent application or other reference was specifically and individually indicated to be incorporated by reference in its entirety for all purposes. Citation of a reference herein shall not be construed as an admission that such is prior art to the present invention.
-
SEQUENCE LISTINGS (Psilocybe cubensis (PSID gene)) SEQ ID NO: 1 ATGCAAGTCATCCCCGCGTGCAACAGCGCAGCTAT AAGGTCACTTTGTCCGACCCCCGAGAGCTTTAGAA ATATGGGCTGGCTTTCCGTGAGCGATGCCGTCTAT AGCGAATTTATAGGTGAACTTGCGACGAGAGCATC TAATAGAAACTACAGCAATGAGTTCGGTTTAATGC AACCAATACAAGAATTTAAAGCGTTCATCGAGAGT GATCCCGTTGTACACCAAGAGTTTATCGACATGTT TGAAGGCATCCAAGATTCTCCGAGGAACTACCAAG AACTATGTAACATGTTCAATGATATTTTTAGGAAG GCTCCCGTATACGGAGATTTGGGCCCTCCGGTCTA CATGATTATGGCGAAGTTGATGAATACAAGGGCGG GTTTCAGTGCGTTCACAAGACAACGTCTGAACCTG CATTTTAAAAAGCTGTTCGATACCTGGGGTTTATT TCTTTCATCCAAAGACAGCAGGAATGTCCTGGTAG CTGACCAGTTTGATGATAGGCACTGCGGCTGGCTG AACGAGAGGGCATTATCTGCGATGGTGAAACACTA TAATGGGCGTGCATTTGATGAAGTATTTCTATGTG ACAAAAATGCACCCTATTACGGCTTTAATTCATAC GACGATTTCTTCAATAGGAGGTTCCGTAATAGAGA CATTGATAGACCCGTTGTCGGCGGCGTGAACAACA CGACGCTTATATCAGCAGCCTGTGAGTCTCTGTCT TATAACGTCAGCTATGACGTGCAATCCTTAGATAC TTTAGTTTTCAAAGGTGAGACGTACTCATTAAAAC ATCTTTTGAATAATGATCCATTTACGCCACAATTC GAGCACGGTTCCATATTGCAAGGATTCCTAAACGT GACAGCATATCATCGTTGGCACGCGCCGGTTAACG GAACTATCGTCAAGATAATCAACGTTCCTGGTACT TATTTCGCACAAGCGCCGTCTACCATCGGTGATCC GATCCCAGATAATGACTATGATCCACCGCCATATC TAAAGAGTCTTGTGTACTTCAGTAACATTGCAGCG AGACAGATTATGTTCATAGAAGCTGATAACAAGGA GATAGGCCTAATTTTCCTGGTTTTTATAGGCATGA CAGAAATTTCAACGTGTGAAGCAACGGTATCCGAG GGGCAACATGTCAATAGAGGGGACGACCTGGGTAT GTTTCATTTCGGGGGCTCTTCTTTTGCCCTTGGCC TGCGTAAAGACTGCCGTGCCGAAATTGTTGAGAAG TTCACGGAGCCCGGGACAGTTATAAGGATTAACGA AGTCGTCGCCGCCTTGAAGGCTTAA (Psilocybe cyanescens (PSID gene)) SEQ ID NO: 2 ATGCAAGTGCTTCCTGCTTGCCAAAGCTCTGCCCT TAAAACCCTGTGTCCGAGCCCCGAGGCTTTTAGAA AGCTGGGATGGCTACCTACGTCTGACGAAGTGTAC AACGAGTTCATAGATGATCTGACTGGCAGGACTTG CAATGAGAAGTATAGCAGCCAAGTAACCCTGTTAA AGCCAATCCAAGACTTCAAGACTTTCATAGAGAAT GACCCGATAGTATATCAAGAGTTCATTAGCATGTT TGAGGGCATAGAACAGAGCCCTACTAACTATCATG AGCTATGTAACATGTTCAACGATATTTTTCGTAAG GCACCCCTATACGGAGACTTAGGACCACCTGTCTA CATGATAATGGCACGTATTATGAATACGCAGGCGG GTTTTTCAGCGTTCACCAAAGAATCTCTGAACTTC CATTTTAAGAAGCTATTCGACACGTGGGGTCTATT CCTAAGCTCTAAAAATTCCAGAAACGTACTTGTCG CCGATCAGTTTGACGACAAACATTACGGATGGTTT TCTGAGAGAGCAAAGACTGCGATGATGATCAACTA TCCAGGACGTACATTCGAGAAGGTCTTCATCTGTG ACGAGCATGTGCCTTATCACGGATTTACTTCCTAT GACGACTTCTTTAACAGGAGATTTCGTGACAAGGA TACAGACCGTCCCGTCGTCGGTGGCGTCACCGACA CGACGTTGATAGGCGCGGCATGTGAAAGTTTATCT TATAACGTTTCTCACAACGTCCAATCACTGGACAC CCTTGTCATAAAAGGCGAGGCGTACTCTTTAAAAC ACCTTCTGCATAATGACCCATTTACGCCACAGTTT GAACATGGATCTATCATCCAAGGATTCTTGAACGT TACAGCCTATCACAGATGGCACTCTCCAGTTAACG GCACTATTGTGAAGATTGTAAACGTACCAGGGACA TACTTTGCCCAGGCGCCCTATACCATAGGTAGCCC AATCCCTGATAATGACCGGGACCCGCCGCCCTACT TGAAGAGCCTTGTTTATTTTAGCAACATTGCTGCC AGACAGATTATGTTTATTGAGGCTGACAATAAAGA TATTGGCCTTATCTTTCTTGTGTTCATTGGCATGA CTGAAATTAGCACATGTGAAGCGACGGTATGCGAA GGACAGCACGTTAACAGAGGCGATGACCTTGGGAT GTTTCATTTTGGGGGATCGAGTTTTGCATTGGGGC TTAGAAAAGATAGCAAAGCAAAAATACTAGAAAAA TTTGCAAAGCCGGGAACAGTAATAAGGATTAACGA GCTGGTGGCATCCGTCAGAAAATAA (Gymnopilus junonius (PSID gene)) SEQ ID NO: 3 ATGTCATCTCCTCGTATCGTGCTGCACAGGGTTGG TGGCTGGCTGCCTAAAGACCAAAACGTGCTAGAAG CATGGCTGAGCAAGAAGATTGCTAAAGCAAAAACT AGAAATAGGGCTCCAAAAGATTGGGCTCCTGTGAT TCAAGACTTCCAGAGACTGATAGAGACCGATGCCG AGATCTACATGGGTTTCCATCAGATGTTCGAGCAG GTCCCCAAGAAAACTCCGTACGATAAAGACCCCAC CAATGAGCAATGGCAAGTAAGAAATTATATGCACA TGTTAGATCTGTTCGACCTAATTATAACCGAGGCA CCGGATTTCGAACAAAATGATCTTGTTGGATTTCC AATAAATGCAATCCTGGATTGGCCCATGGGGACCC CCGGTGGGCTTACTGCATTTATTAACCCTAAAGTA AATATTATGTTTCATAAAATGTTTGACGTTTGGGC AGTATTTCTGTCATCTCCAGCATCATGCTACGTCC TAAATACAAGCGATAGCGGTTGGTTCGGTCCCGCT GCAACCGCAGCTATACCCAACTTCAAAGAGACCTT CATCTGCGACCCAAGTCTGCCATACCTAGGGTACA CTAGCTGGGATAATTTCTTCACCAGGCTGTTTAGG CCGGGGGTGCGTCCTGTCGAGTTCCCGAACAATGA TGCCATTGTTAACAGTGCGTGTGAATCCACGGTTT ATAATATAGCTCCAAACATTAAACCACTAGATAAA TTTTGGATTAAGGGAGAGCCGTATTCCCTAAATCA CATACTTAATAACGACCCGTACGCGAGCCAGTTCG TAGGTGGAACCATATCCCAAGCATTCTTATCTGCG CTGAACTATCACCGTTGGGCGAGTCCGGTTAACGG CAACATTGTCAAGGTCGTCAATGTTCCGGGTACAT ACTACGCGGAGTCCCCAGTTACCGGTTTTGGGAAT CCAGAAGGGCCAGATCCAGCGGCGCCCAATCTATC TCAAGGTTTCATTACTGCTGTGGCTGCGAGAGCCC TGATTTTCATAGAGGCCGATAACCCTAACATCGGA TTAATGTGTTTTGTGGGGGTTGGCATGGCAGAGGT CTCAACATGTGAAGTTACCGTGAGTGTAGGCGATG TTGTCAAGAAAGGAGATGAGATTGGAATGTTCCAT TTCGGGGGAAGCACTCACTGCTTGATATTTAGGCC ACAAACAAAAATTACGTTCAATCCCGACTATCCTG TGTCAACCGCCGTACCCTTGAATGCTGCAGTGGCA ACCGTCGTATAA (Psilocybe cubensis (PSIH gene)) SEQ ID NO: 4 ATGATTGCCGTCTTATTCTCTTTTGTCATAGCTGG CTGCATCTATTATATAGTATCCCGTCGTGTGCGTC GTTCAAGACTTCCGCCCGGACCACCAGGCATCCCT ATCCCCTTTATCGGCAATATGTTTGACATGCCCGA AGAATCACCCTGGTTGACGTTTCTGCAATGGGGCA GAGATTATAATACAGACATTTTGTATGTAGATGCA GGCGGAACTGAGATGGTAATATTGAATACCCTTGA GACAATCACTGATTTGTTAGAAAAGAGGGGGTCTA TATATTCTGGCAGGCTAGAAAGTACCATGGTTAAT GAGTTGATGGGGTGGGAGTTTGATCTAGGATTCAT CACCTACGGTGATCGTTGGAGAGAGGAGAGAAGGA TGTTCGCGAAAGAGTTCAGCGAAAAGGGAATCAAA CAATTCAGGCACGCCCAAGTAAAGGCGGCGCATCA ACTTGTCCAACAGCTGACAAAAACACCGGATCGTT GGGCTCAACACATACGTCATCAGATAGCCGCCATG TCTTTAGACATCGGCTATGGCATAGACTTAGCGGA GGATGATCCATGGTTAGAAGCAACACACTTAGCTA ACGAAGGACTGGCGATAGCTTCCGTCCCAGGAAAA TTTTGGGTAGACTCATTTCCGTCTCTGAAATACCT ACCAGCCTGGTTTCCTGGAGCTGTCTTCAAACGTA AGGCAAAAGTATGGAGGGAGGCAGCAGACCATATG GTGGACATGCCATATGAGACTATGAGGAAATTGGC GCCACAGGGCTTGACTAGACCATCCTATGCATCTG CAAGACTACAGGCCATGGACCTAAACGGTGATTTG GAGCACCAAGAGCACGTAATTAAAAACACAGCAGC CGAAGTGAACGTCGGAGGGGGAGATACAACCGTCT CTGCGATGAGTGCGTTCATACTAGCGATGGTCAAG TATCCGGAAGTACAGCGTAAAGTCCAGGCCGAGCT AGACGCACTTACTAACAACGGCCAGATTCCCGATT ACGACGAGGAAGACGATAGTCTACCTTACTTGACC GCATGTATTAAAGAGTTATTTAGATGGAATCAAAT TGCGCCCCTAGCGATTCCTCACAAGTTAATGAAAG ACGATGTATATAGGGGTTATCTAATACCTAAGAAT ACGCTAGTTTTTGCAAACACATGGGCGGTCCTGAA CGACCCTGAAGTCTACCCAGACCCTAGCGTATTTA GGCCGGAGCGTTATTTAGGACCCGACGGTAAGCCC GATAATACTGTCAGGGACCCCAGGAAGGCTGCGTT CGGGTATGGGAGGAGGAACTGTCCAGGAATACACT TAGCCCAATCAACCGTCTGGATAGCCGGAGCGACC TTACTTAGTGCGTTTAATATCGAGAGGCCAGTTGA CCAGAATGGGAAACCCATCGATATTCCAGCAGACT TCACAACCGGGTTTTTCAGGCATCCTGTTCCTTTT CAGTGCCGTTTCGTGCCTAGGACTGAACAGGTCTC CCAATCAGTCAGTGGGCCGTAA (Psilocybe cyanescens (PSIH gene)) SEQ ID NO: 5 ATGGCGCCTTTGACAACCATGATTCCGATCGTTCT ATCTCTTCTAATAGCGGGGTGTATATATTATATCA ACGCAAGGAGAATTAAAAGGTCCAGGTTGCCACCA GGACCGCCGGGTATTCCTATTCCATTCATCGGGAA CATGTTCGACATGCCAAGCGAAAGTCCCTGGCTAA TCTTCCTACAATGGGGACAAGAGTACCAGACCGAT ATAATTTACGTTGACGCGGGAGGAACTGATATGAT AATACTTAATTCCCTAGAGGCAATTACAGATCTGT TAGAGAAAAGGGGCTCATTGTATAGCGGGAGGTTG GAATCCACGATGGTAAACGAGCTAATGGGTTGGGA GTTTGATTTCGGTTTCATACCTTACGGTGAAAGAT GGAGGGAAGAACGTCGTATGTTCGCCAAAGAGTTT TCTGAGAAGAACATAAGGCAGTTTAGACACGCCCA AGTAAAGGCTGCCAATCAGCTAGTGCGTCAACTAA CCGATAAACCGGACAGGTGGTCACACCACATAAGG CATCAAATCGCGTCCATGGCCCTGGACATCGGTTA CGGAATCGATCTTGCTGAAGACGATCCGTGGATCG CAGCTTCCGAACTGGCGAATGAAGGCTTGGCTGTA GCCTCAGTGCCAGGATCTTTTTGGGTAGATACGTT CCCGTTTCTTAAATATTTGCCAAGTTGGTTACCTG GCGCGGAGTTCAAAAGAAACGCAAAGATGTGGAAG GAAGGAGCAGATCATATGGTCAATATGCCTTACGA AACGATGAAAAAGCTAAGCGCACAAGGACTGACTA GACCATCATATGCAAGTGCGAGGCTACAGGCTATG GACCCGAACGGGGATCTTGAACATCAAGAAAGAGT GATCAAAAATACGGCCACGCAGGTAAATGTTGGTG GTGGGGATACTACAGTCGGGGCAGTAAGTGCGTTT ATCCTTGCGATGGTAAAATACCCGGAAGTTCAAAG GAAAGTACAAGCCGAGCTGGACGAGTTCACGAGCA AGGGGAGGATACCGGATTACGATGAAGATAACGAT TCTCTTCCCTATCTATCGGCTTGCTTCAAAGAGCT GTTCAGGTGGGGCCAGATTGCGCCTTTGGCGATTG CTCATAGGCTGATAAAGGACGATGTCTATAGGGAA TATACTATCCCAAAGAATGCTCTGGTCTTTGCGAA CAATTGGTATGGGCGTACTGTATTGAATGACCCTT CTGAGTATCCCAATCCTTCAGAATTTAGACCTGAA AGGTACTTGGGGCCCGATGGTAAGCCAGATGACAC CGTCAGGGACCCAAGAAAGGCAGCGTTTGGGTACG GACGTAGAGTGTGTCCAGGGATACACCTGGCGCAG AGCACGGTCTGGATTGCTGGTGTCGCGTTGGTATC TGCCTTCAACATTGAGCTGCCCGTGGACAAAGACG GGAAATGTATAGATATTCCGGCGGCCTTCACGACG GGATTCTTTAGATAA (Gymnopilus junonius (PSIH gene)) SEQ ID NO: 6 ATGATGTCCGAGATGAATGGGATGGATAAATTGGC GCTATTGACGACGTTATTAGCTGCCGGTTTTCTAT ACTTCAAGAATAAGCGTCGTTCCGCGTTGCCGTTC CCGCCAGGGCCGAAAAAGCATCCCCTTTTAGGTAA CTTGCTGGACCTTCCGAAGAAGCTGGAGTGGGAGA CGTACAGAAGATGGGGAAAAGAATACAATTCAGAT GTAATACATGTTAGCGCGGGGAGTGTAAACTTAAT TATCGTTAATTCCTTTGAAGCTGCGACAGACCTGT TTGATAAGAGATCAGCCAATTATTCAAGTAGGCCA CAATTCACGATGGTGAGAGAACTGATGGGATGGAA TTGGTTGATGTCTGCATTAATATACGGTGACAAGT GGAGAGAGCAACGTAGGTTGTTTCAGAAACATTTC AGTACAACGAATGCCGAACTTTACCAAAATACACA ATTAGAATATGTTCGTAAAGCCCTGCAGCATCTGC TAGAAGAGCCTTCAGATTTTATGGGAATAACACGT CACATGGCTGGGGGCGTCAGCATGTCCCTGGCATA TGGCTTAAACATTCAGAAGAAAAACGACCCTTTTG TTGACCTTGCACAAAGGGCAGTGCACAGCATAACA GAGGCCTCAGTTCCTGGGACATTTTGGGTAGACGT AATGCCTTGGCTAAAGTATATTCCAGAATGGGTGC CGGGTGCTGGCTTTCAGAAGAAGGCTAGAGTGTGG AGGAAATTACAGCAAGATTTTCGTCAGGTCCCATA TCAGGCAGCTCTGAAAGACATGGCTTCAGGGAAAG CTAAACCATCATTTGCAAGTGAGTGTTTGGAGACG ATAGACGACAATGAGGATGCACAAAGGCAAAGGGA GGTGATAAAAGACACAGCTGCCATTGTATTCGCAG CCGGTGCGGATACAAGCCTTAGTGGAATCCATACA TTATTCGCCGCAATGTTGTGTTACCCAGAGGTCCA GAAGAAAGCACAAGAAGAACTGGATCGTGTCTTGG GTGGGAGACGTCTACCGGAATTTACCGATGAGCCC AACATGCCCTACATCTCTGCGTTAGTGAAGGAAAT ATTGAGGTGGAAACCGGCTACTCCGATTGGCGTAC CCCACTTAGCCAGCGAGGATGACGTTTACAACGGA TATTACATACCAAAACGTGCGGTTGTCATAGGCAA CAGCTGGGCTATGCTTCATGATGAGGAAACTTATC CGGACCCAAGCACCTTTAACCCTGACAGATTTTTG ACCACAAATAAAAGCACTGGAAAATTGGAATTAGA TCCCACAGTGAGAGATCCCGCTTTAATGGCCTTCG GATTTGGTAGACGTATGTGTCCAGGACGTGATGTA GCTCTTTCTGTCATATGGCTGACTATCGCAAGCGT TTTAGCAACGTTTAATATTACCAAGGCGATAGACG AAAACGGGAAGGAACTGGAACCGGATGTACAGTAC TGGAGCGGTCTAATCGTCCACCCGCTGCCATTCAA ATGTACGATCAAGCCAAGATCAAAGGCAGCGGAAG AACTTGTGAAATCTGGCGCAGACGCCTATTAA (Psilocybe cubensis (PSIK gene)) SEQ ID NO: 7 ATGGCATTCGACTTGAAAACTGAAGACGGGCTAAT AACTTACCTAACGAAACACCTTTCTTTGGATGTGG ATACATCAGGTGTGAAAAGGTTAAGCGGTGGCTTC GTTAACGTGACCTGGAGAATAAAACTAAACGCACC CTATCAGGGTCACACATCAATAATTCTAAAGCACG CACAGCCGCATATGTCAACCGACGAAGACTTCAAA ATTGGCGTGGAGCGTTCCGTCTATGAGTACCAGGC TATCAAACTTATGATGGCCAATAGGGAGGTGCTAG GGGGTGTTGACGGGATCGTGTCTGTGCCAGAGGGG TTGAACTACGACCTTGAAAATAATGCATTGATCAT GCAGGACGTAGGTAAGATGAAGACCCTATTAGACT ACGTAACGGCAAAACCCCCGCTTGCGACTGATATA GCACGTTTGGTAGGTACAGAGATTGGGGGTTTCGT GGCTAGACTGCATAACATAGGGAGGGAGAGGAGAG ACGACCCGGAGTTCAAGTTTTTCTCTGGAAATATA GTCGGCAGGACAACAAGCGATCAACTATACCAAAC AATTATCCCTAACGCAGCTAAGTACGGGGTAGATG ACCCTCTACTGCCTACCGTTGTAAAAGATCTGGTC GATGATGTCATGCACAGTGAGGAGACTCTTGTAAT GGCGGATTTATGGAGCGGCAATATACTTCTACAGT TGGAGGAGGGGAATCCTTCAAAGTTACAGAAAATC TACATTTTAGATTGGGAATTGTGTAAATACGGCCC AGCTTCACTAGACCTTGGGTATTTCTTGGGTGATT GCTACCTGATTTCTCGTTTCCAAGATGAGCAGGTC GGCACAACTATGAGACAAGCCTACTTACAAAGCTA CGCTCGTACCTCTAAACATTCCATAAACTACGCCA AGGTCACTGCGGGAATTGCAGCACATATAGTGATG TGGACAGACTTTATGCAGTGGGGGAGTGAGGAAGA GAGAATTAACTTCGTCAAGAAAGGCGTGGCCGCCT TCCATGACGCAAGAGGGAACAATGATAATGGTGAA ATCACCTCTACTCTGTTGAAGGAGAGTTCAACTGC CTAA (Psilocybe cyanescens (PSIK gene)) SEQ ID NO: 8 ATGACTTTCGATCTAAAAACGGAGGAGGGCTTATT ATCTTATCTTACCAAGCATTTAAGTTTAGACGTAG CACCGAATGGTGTCAAAAGATTATCTGGTGGATTC GTCAATGTGACTTGGAGGGTAGGGTTAAATGCACC GTACCATGGGCACACGTCTATAATCCTTAAACACG CTCAACCACATTTAAGCTCCGATATTGACTTCAAA ATAGGGGTGGAAAGAAGTGCGTATGAGTACCAGGC TTTGAAGATTGTCTCTGCCAACAGCAGCCTACTTG GTTCTTCTGATATCCGTGTCTCAGTTCCAGAAGGT TTGCACTATGATGTTGTGAATAACGCCCTAATCAT GCAGGACGTGGGTACAATGAAGACCTTGCTGGACT ATGTTACAGCGAAACCCCCTATATCTGCTGAAATT GCCAGCCTAGTAGGTAGTCAGATTGGCGCTTTCAT AGCAAGATTACACAATTTGGGCAGAGAAAATAAAG ATAAGGACGACTTTAAATTTTTCTCCGGAAATATA GTTGGGAGGACGACGGCAGACCAACTGTATCAGAC CATAATTCCTAATGCGGCAAAATATGGAATCGATG ACCCAATTCTTCCAATAGTTGTCAAAGAACTTGTT GAAGAAGTCATGAACTCAGAGGAAACCCTGATTAT GGCGGACCTATGGAGCGGTAATATCTTGCTACAGT TCGACGAGAACAGTACGGAACTAACCCGTATTTGG CTGGTAGACTGGGAGCTATGCAAGTACGGGCCGCC GTCACTGGATATGGGTTACTTCTTGGGCGACTGCT TTTTGGTAGCTAGATTCCAAGACCAACTTGTAGGC ACATCTATGAGACAAGCATACCTTAAAAGCTACGC ACGTAACGTAAAAGAGCCGATCAACTATGCTAAGG CCACAGCAGGCATCGGCGCTCATTTGGTAATGTGG ACTGACTTCATGAAGTGGGGTAACGATGAAGAAAG GGAGGAGTTCGTGAAAAAGGGGGTCGAAGCATTCC ACGAGGCCAACGAAGACAATAGGAACGGAGAGATA ACGAGCATATTGGTGAAAGAGGCATCACGTACGTA A (Psilocybe cubensis (PSIM gene)) SEQ ID NO: 9 ATGCACATCAGAAACCCCTATAGAACCCCCATAGA TTACCAGGCGCTGAGTGAGGCCTTTCCACCATTGA AGCCCTTTGTATCCGTAAACGCTGATGGTACGAGT TCCGTAGATCTAACGATCCCGGAGGCGCAACGTGC GTTCACTGCCGCATTGTTACATAGAGATTTCGGGC TAACCATGACTATACCGGAAGATAGACTGTGCCCT ACTGTCCCTAACAGGTTAAATTATGTACTGTGGAT TGAAGATATTTTCAACTACACGAATAAGACCCTGG GGCTGAGCGATGACAGACCGATAAAGGGGGTGGAT ATTGGCACAGGCGCCAGCGCAATATACCCTATGCT TGCTTGCGCCAGGTTTAAGGCATGGTCCATGGTAG GGACAGAGGTAGAACGTAAATGTATTGATACGGCT AGACTAAATGTCGTCGCCAATAATCTACAGGATAG ATTGAGTATATTAGAGACATCCATCGACGGTCCCA TTCTTGTTCCAATCTTCGAGGCCACAGAAGAATAT GAGTATGAGTTCACCATGTGTAATCCGCCATTCTA CGATGGTGCGGCCGACATGCAGACCTCTGACGCGG CCAAAGGATTCGGCTTTGGAGTGGGGGCCCCTCAC TCTGGAACAGTTATCGAAATGTCCACTGAAGGAGG GGAGTCCGCATTCGTAGCCCAGATGGTGAGAGAGA GCTTGAAACTGCGTACCAGATGCAGATGGTATACG TCTAATCTTGGGAAATTAAAAAGCCTAAAGGAGAT TGTGGGTCTTTTAAAAGAGCTGGAGATTTCCAACT ACGCCATAAACGAGTACGTCCAAGGGTCTACCAGA AGATACGCCGTCGCGTGGTCTTTTACTGACATTCA GCTTCCAGAGGAGCTATCTCGTCCCAGTAACCCGG AATTGTCCTCCTTGTTTTAA (Psilocybe cyanescens (PSIM gene)) SEQ ID NO: 10 ATGCATATCAGGAATCCGTACCGTGACGGCGTGGA CTACCAGGCATTAGCCGAGGCTTTCCCGGCGCTAA AGCCACACGTCACTGTCAATTCAGACAATACAACT TCTATAGATTTCGCGGTACCCGAGGCCCAGAGACT TTACACCGCAGCATTACTTCATAGGGACTTTGGTT TAACCATAACCTTACCCGAGGATAGACTATGTCCT ACGGTCCCGAATAGATTGAACTATGTGTTGTGGGT GGAAGATATACTGAAGGTTACGTCAGACGCATTGG GATTACCGGATAATAGACAAGTGAAAGGTATTGAT ATTGGAACAGGAGCAAGCGCAATTTATCCCATGTT AGCTTGTTCCAGGTTTAAGACTTGGTCCATGGTAG CTACAGAGGTGGATCAAAAATGCATAGATACCGCA AGGCTAAACGTAATAGCTAATAACCTTCAGGAGAG ATTGGCAATCATAGCCACTTCCGTGGACGGGCCTA TTCTTGTTCCTCTGTTGCAGGCTAATTCCGACTTT GAATATGACTTCACCATGTGCAATCCGCCCTTTTA CGACGGCGCCTCTGATATGCAGACAAGTGATGCCG CTAAAGGCTTTGGCTTCGGAGTAAACGCACCTCAC ACTGGGACAGTACTTGAAATGGCGACAGAAGGAGG GGAAAGTGCGTTCGTTGCCCAAATGGTTCGTGAGT CCTTGAACCTGCAGACTAGATGCAGGTGGTTCACA TCTAATTTGGGTAAACTAAAATCACTGTACGAGAT TGTGGGTCTATTAAGAGAACACCAGATTTCTAACT ACGCCATAAATGAGTATGTACAAGGCGCAACTCGT AGGTATGCAATTGCGTGGAGTTTCATAGATGTAAG ACTGCCCGACCATTTGTCCAGACCATCTAATCCCG ATCTATCCAGTTTGTTTTAA (Panaeolus cyanescens (PSIM gene)) SEQ ID NO: 11 ATGCATAACCGTAACCCGTATAGGGACGTGATTGA TTACCAAGCACTTGCGGAAGCCTACCCGCCCCTAA AACCCCACGTCACGGTGAACGCGGATAACACGGCA TCCATAGATCTTACGATCCCCGAGGTCCAGAGGCA ATACACAGCAGCTCTTTTACATCGTGATTTCGGAT TAACTATCACACTACCAGAAGATAGGCTGTGCCCG ACAGTACCGAACCGTTTAAACTATGTATTGTGGAT AGAGGATATATTTCAGTGTACGAATAAGGCTCTGG GATTGTCAGATGACAGACCCGTTAAGGGGGTAGAT ATAGGGACCGGCGCCTCCGCCATCTATCCAATGCT TGCTTGCGCGAGGTTTAAGCAGTGGTCCATGATTG CCACAGAAGTGGAGCGTAAGTGCATAGATACAGCG AGATTGAATGTCCTGGCGAATAACTTACAGGACCG TTTGTCAATTCTTGAGGTTTCAGTAGACGGCCCGA TTTTGGTACCCATCTTTGATACCTTCGAGCGTGCG ACAAGCGATTACGAATTTGAGTTCACGATGTGTAA CCCTCCATTTTACGACGGGGCCGCGGATATGCAAA CATCAGATGCAGCTAAGGGTTTCGGTTTTGGAGTT AACGCTCCACACTCCGGTACCGTGATAGAGATGGC TACTGAAGGAGGTGAGGCTGCTTTTGTGGCGCAAA TGGTCCGTGAGAGCATGAAGTTACAGACAAGGTGT CGTTGGTTTACAAGCAACTTAGGCAAGCTAAAATC ACTGCATGAAATTGTTGCTTTGTTGAGAGAATCCC AGATCACAAACTATGCCATAAATGAGTACGTTCAG GGGACGACGAGAAGGTACGCTCTTGCTTGGTCCTT CACAGACATAAAACTTACTGAGGAACTTTACAGGC CCTCCAATCCAGAATTAGGACCTCTTTGCAGCACA TTTGTCTAA (Gymnopilus dilepis (PSIM gene)) SEQ ID NO: 12 ATGCACATTAGAAACCCTTACTTAACACCTCCGGA CTACGAGGCCCTTGCGGAGGCCTTCCCCGCACTAA AGCCTTATGTTACAGTTAACCCCGATAAGACTACT ACAATTGACTTTGCCATACCGGAGGCTCAGAGATT ATACACGGCTGCTCTACTTTACAGGGACTTTGGAC TGACAATAACATTGCCGCCGGATAGGTTATGCCCA ACCGTGCCCAATAGGCTTAATTATGTTTTGTGGAT TCAGGACATTCTGCAGATTACCTCCGCTGCCTTGG GCTTGCCAGAGGCTAGACAAGTAAAGGGAGTAGAC ATAGGTACCGGAGCGGCAGCGATATACCCTATTCT TGGTTGCAGCCTTGCAAAGAATTGGTCTATGGTGG GGACAGAGGTCGAACAAAAATGTATCGACATAGCG CGTCAAAACGTGATTTCAAATGGATTGCAGGATAG GATAACCATAACTGCTAATACCATAGACGCTCCCA TTCTGCTGCCCTTATTTGAAGGAGACAGTAACTTC GAATGGGAGTTCACCATGTGTAACCCGCCATTTTA CGACGGCGCTGCGGACATGGAGACAAGCCAGGACG CTAAAGGCTTCGGGTTCGGCGTCAACGCCCCGCAT ACAGGAACAGTGGTGGAAATGGCCACGGACGGTGG TGAGGCTGCATTCGTCAGCCAAATGGTGAGAGAGT CCTTGCACCTAAAGACACGTTGTAGATGGTTCACG TCCAATCTAGGTAAATTGAAGAGTCTACATGAAAT TGTGGGATTGTTGCGTGAACACCAAATTACCAACT ACGCGATAAATGAATATGTTCAGGGAACGACACGT AGATACGCGATTGCATGGTCATTTACTGACCTACG TCTATCAGACCACCTGCCACGTCCTCCGAACCCCG ATCTATCAGCCCTATTTTAA (Gymnopilus junonius (PSIM gene)) SEQ ID NO: 13 ATGCACTCTCGTAACCCTTATAGATCCCCTCCTGA TTTCGCGGCATTAAGTGCGGCTTATCCTCCGCTGT CACCATACATAACTACCGATCTAAGCAGCGGTCGT AAAACAATTGACTTTAGAAATGAGGAAGCGCAACG TCGTCTAACTGAGGCTATCATGTTGCGTGACTTCG GCGTTGTGTTAAACATACCATCTAACAGGCTGTGC CCGCCTGTGCCGAATCGTATGAACTATGTACTTTG GATACAAGATATAGTTTACGCGCACCAGACAATAC TGGGAGTGAGTTCTCGTCGTATCAGAGGTCTTGAT ATTGGTACTGGTGCTACCGCTATATATCCTATACT GGCATGCAAGAAAGAGCAGAGCTGGGAGATGGTTG CAACTGAATTGGACGACTACTCCTATGAGTGTGCA TGTGATAACGTGTCATCCAACAATATGCAGACTTC CATTAAAGTAAAGAAGGCTTCGGTAGATGGGCCCA TCCTGTTCCCAGTGGAAAACCAAAATTTCGACTTT AGCATGTGCAACCCGCCTTTCTACGGCTCTAAGGA GGAGGTGGCGCAATCCGCAGAGTCAAAAGAACTGC CGCCCAATGCTGTTTGCACGGGTGCAGAGATCGAG ATGATATTTAGTCAAGGAGGAGAAGAGGGTTTCGT AGGTAGAATGGTAGAGGAATCAGAGAGGTTGCAAA CGAGATGCAAATGGTACACTTCAATGCTTGGTAAG ATGTCTAGTGTAAGCACTATAGTTCAGGCTCTGCG TGCGAGATCAATTATGAATTATGCTTTGACAGAAT TTGTACAAGGACAAACCCGTAGGTGGGCGATAGCT TGGTCTTTCTCCGACACTCACTTACCGGATGCCGT CAGTAGAATCTCTAGTTAA (Psilocybe cubensis (PSID gene)) SEQ ID NO: 14 MQVIPACNSAAIRSLCPTPESFRNMGWLSVSDAVY SEFIGELATRASNRNYSNEFGLMQPIQEFKAFIES DPVVHQEFIDMFEGIQDSPRNYQELCNMFNDIFRK APVYGDLGPPVYMIMAKLMNTRAGFSAFTRQRLNL HFKKLFDTWGLFLSSKDSRNVLVADQFDDRHCGWL NERALSAMVKHYNGRAFDEVFLCDKNAPYYGFNSY DDFFNRRFRNRDIDRPVVGGVNNTTLISAACESLS YNVSYDVQSLDTLVFKGETYSLKHLLNNDPFTPQF EHGSILQGFLNVTAYHRWHAPVNGTIVKIINVPGT YFAQAPSTIGDPIPDNDYDPPPYLKSLVYFSNIAA RQIMFIEADNKEIGLIFLVFIGMTEISTCEATVSE GQHVNRGDDLGMFHFGGSSFALGLRKDCRAEIVEK FTEPGTVIRINEVVAALKA (Psilocybe cyanescens (PSID gene)) SEQ ID NO: 15 MQVLPACQSSALKTLCPSPEAFRKLGWLPTSDEVY NEFIDDLTGRTCNEKYSSQVTLLKPIQDFKTFIEN DPIVYQEFISMFEGIEQSPTNYHELCNMFNDIFRK APLYGDLGPPVYMIMARIMNTQAGFSAFTKESLNF HFKKLFDTWGLFLSSKNSRNVLVADQFDDKHYGWF SERAKTAMMINYPGRTFEKVFICDEHVPYHGFTSY DDFFNRRFRDKDTDRPVVGGVTDTTLIGAACESLS YNVSHNVQSLDTLVIKGEAYSLKHLLHNDPFTPQF EHGSIIQGFLNVTAYHRWHSPVNGTIVKIVNVPGT YFAQAPYTIGSPIPDNDRDPPPYLKSLVYFSNIAA RQIMFIEADNKDIGLIFLVFIGMTEISTCEATVCE GQHVNRGDDLGMFHFGGSSFALGLRKDSKAKILEK FAKPGTVIRINELVASVRK (Gymnopilus junonius (PSID gene)) SEQ ID NO: 16 MSSPRIVLHRVGGWLPKDQNVLEAWLSKKIAKAKT RNRAPKDWAPVIQDFQRLIETDAEIYMGFHQMFEQ VPKKTPYDKDPTNEQWQVRNYMHMLDLFDLIITEA PDFEQNDLVGFPINAILDWPMGTPGGLTAFINPKV NIMFHKMFDVWAVFLSSPASCYVLNTSDSGWFGPA ATAAIPNFKETFICDPSLPYLGYTSWDNFFTRLFR PGVRPVEFPNNDAIVNSACESTVYNIAPNIKPLDK FWIKGEPYSLNHILNNDPYASQFVGGTISQAFLSA LNYHRWASPVNGNIVKVVNVPGTYYAESPVTGFGN PEGPDPAAPNLSQGFITAVAARALIFIEADNPNIG LMCFVGVGMAEVSTCEVTVSVGDVVKKGDEIGMFH FGGSTHCLIFRPQTKITFNPDYPVSTAVPLNAAVA TVV (Psilocybe cubensis (PSIH gene)) SEQ ID NO: 17 MIAVLFSFVIAGCIYYIVSRRVRRSRLPPGPPGIP IPFIGNMFDMPEESPWLTFLQWGRDYNTDILYVDA GGTEMVILNTLETITDLLEKRGSIYSGRLESTMVN ELMGWEFDLGFITYGDRWREERRMFAKEFSEKGIK QFRHAQVKAAHQLVQQLTKTPDRWAQHIRHQIAAM SLDIGYGIDLAEDDPWLEATHLANEGLAIASVPGK FWVDSFPSLKYLPAWFPGAVFKRKAKVWREAADHM VDMPYETMRKLAPQGLTRPSYASARLQAMDLNGDL EHQEHVnCNTAAEVNVGGGDTTVSAMSAFILAMVK YPEVQRKVQAELDALTNNGQIPDYDEEDDSLPYLT ACIKELFRWNQIAPLAIPHKLMKDDVYRGYLIPKN TLVFANTWAVLNDPEVYPDPSVFRPERYLGPDGKP DNTVRDPRKAAFGYGRRNCPGIHLAQSTVWIAGAT LLSAFNIERPVDQNGKPIDIPADFTTGFFRHPVPF QCRFVPRTEQVSQSVSGP (Psilocybe cyanescens (PSIH gene)) SEQ ID NO: 18 MAPLTTMIPIVLSLLIAGCIYYINARRIKRSRLPP GPPGIPIPFIGNMFDMPSESPWLIFLQWGQEYQTD IIYVDAGGTDMIILNSLEAITDLLEKRGSLYSGRL ESTMVNELMGWEFDFGFIPYGERWREERRMFAKEF SEKNIRQFRHAQVKAANQLVRQLTDKPDRWSHHIR HQIASMALDIGYGIDLAEDDPWIAASELANEGLAV ASVPGSFWVDTFPFLKYLPSWLPGAEFKRNAKMWK EGADHMVNMPYETMKKLSAQGLTRPSYASARLQAM DPNGDLEHQERVIKNTATQVNVGGGDTTVGAVSAF ILAMVKYPEVQRKVQAELDEFTSKGRIPDYDEDND SLPYLSACFKELFRWGQIAPLAIAHRLIKDDVYRE YTIPKNALVFANNWYGRTVLNDPSEYPNPSEFRPE RYLGPDGKPDDTVRDPRKAAFGYGRRVCPGIHLAQ STVWIAGVALVSAFNIELPVDKDGKCIDIPAAFTT GFFR (Gymnopilus junonius (PSIH gene)) SEQ ID NO: 19 MMSEMNGMDKLALLTTLLAAGFLYFKNKRRSALPF PPGPKKHPLLGNLLDLPKKLEWETYRRWGKEYNSD VIHVSAGSVNLIIVNSFEAATDLFDKRSANYSSRP QFTMVRELMGWNWLMSALIYGDKWREQRRLFQKHF STTNAELYQNTQLEYVRKALQHLLEEPSDFMGITR HMAGGVSMSLAYGLNIQKKNDPFVDLAQRAVHSIT EASVPGTFWVDVMPWLKYIPEWVPGAGFQKKARVW RKLQQDFRQVPYQAALKDMASGKAKPSFASECLET IDDNEDAQRQREVIKDTAAIVFAAGADTSLSGIHT LFAAMLCYPEVQKKAQEELDRVLGGRRLPEFTDEP NMPYISALVKEILRWKPATPIGVPHLASEDDVYNG YYIPKRAVVIGNSWAMLHDEETYPDPSTFNPDRFL TTNKSTGKLELDPTVRDPALMAFGFGRRMCPGRDV ALSVIWLTIASVLATFNITKAIDENGKELEPDVQY WSGLIVHPLPFKCTIKPRSKAAEELVKSGADAY (Psilocybe cubensis (PSIK gene)) SEQ ID NO: 20 MAFDLKTEDGLITYLTKHLSLDVDTSGVKRLSGGF VNVTWRIKLNAPYQGHTSIILKHAQPHMSTDEDFK IGVERSVYEYQAIKLMMANREVLGGVDGIVSVPEG LNYDLENNALIMQDVGKMKTLLDYVTAKPPLATDI ARLVGTEIGGFVARLHNIGRERRDDPEFKFFSGNI VGRTTSDQLYQTIIPNAAKYGVDDPLLPTVVKDLV DDVMHSEETLVMADLWSGNILLQLEEGNPSKLQKI YILDWELCKYGPASLDLGYFLGDCYLISRFQDEQV GTTMRQAYLQSYARTSKHSINYAKVTAGIAAHIVM WTDFMQWGSEEERINFVKKGVAAFHD ARGNNDNG EITSTLLKESSTA (Psilocybe cyanescens (PSIK gene)) SEQ ID NO: 21 MTFDLKTEEGLLSYLTKHLSLDVAPNGVKRLSGGF VNVTWRVGLNAPYHGHTSIILKHAQPHLSSDIDFK IGVERSAYEYQALKIVSANSSLLGSSDIRVSVPEG LHYDVVNNALIMQDVGTMKTLLDYVTAKPPISAEI ASLVGSQIGAFIARLHNLGRENKDKDDFKFFSGNI VGRTTADQLYQTIIPNAAKYGIDDPILPIVVKELV EEVMNSEETLIMADLWSGNILLQFDENSTELTRIW LVDWELCKYGPPSLDMGYFLGDCFLVARFQDQLVG TSMRQAYLKSYARNVKEPINYAKATAGIGAHLVMW TDFMKWGNDEEREEFVKKGVEAFHEANEDNRNGEI TSILVKEASRT (Psilocybe cyanescens (PSIM gene)) SEQ ID NO: 22 MHIRNPYRDGVDYQALAEAFPALKPHVTVNSDNTT SIDFAVPEAQRLYTAALLHRDFGLTITLPEDRLCP TVPNRLNYVLWVEDILKVTSDALGLPDNRQVKGID IGTGASAIYPMLACSRFKTWSMVATEVDQKCIDTA RLNVIANNLQERLAIIATSVDGPILVPLLQANSDF EYDFTMCNPPFYDGASDMQTSDAAKGFGFGVNAPH TGTVLEMATEGGESAFVAQMVRESLNLQTRCRWFT SNLGKLKSLYEIVGLLREHQISNYAINEYVQGATR RYAIAWSFIDVRLPDHLSRPSNPDLSSLF (Psilocybe cubensis (PSIM gene)) SEQ ID NO: 23 MHIRNPYRTPIDYQALSEAFPPLKPFVSVNADGTS SVDLTIPEAQRAFTAALLHRDFGLTMTIPEDRLCP TVPNRLNYVLWIEDIFNYTNKTLGLSDDRPIKGVD IGTGASAIYPMLACARFKAWSMVGTEVERKCIDTA RLNVVANNLQDRLSILETSIDGPILVPIFEATEEY EYEFTMCNPPFYDGAADMQTSDAAKGFGFGVGAPH SGTVIEMSTEGGESAFVAQMVRESLKLRTRCRWYT SNLGKLKSLKEIVGLLKELEISNYAINEYVQGSTR RYAVAWSFTDIQLPEELSRPSNPELSSLF (Panaeolus cyanescens (PSIM gene)) SEQ ID NO: 24 MHNRNPYRDVIDYQALAEAYPPLKPHVTVNADNTA SIDLTIPEVQRQYTAALLHRDFGLTITLPEDRLCP TVPNRLNYVLWIEDIFQCTNKALGLSDDRPVKGVD IGTGASAIYPMLACARFKQWSMIATEVERKCIDTA RLNVLANNLQDRLSILEVSVDGPILVPIFDTFERA TSDYEFEFTMCNPPFYDGAADMQTSDAAKGFGFGV NAPHSGTVIEMATEGGEAAFVAQMVRESMKLQTRC RWFTSNLGKLKSLHEIVALLRESQITNYAINEYVQ GTTRRYALAWSFTDIKLTEELYRPSNPELGPLCST FV (Gymnopilus junonius (PSIM gene)) SEQ ID NO: 25 MHSRNPYRSPPDFAALSAAYPPLSPYITTDLSSGR KTIDFRNEEAQRRLTEAIMLRDFGVVLNIPSNRLC PPVPNRMNYVLWIQDIVYAHQTILGVSSRRIRGLD IGTGATAIYPILACKKEQSWEMVATELDDYSYECA CDNVSSNNMQTSIKVKKASVDGPILFPVENQNFDF SMCNPPFYGSKEEVAQSAESKELPPNAVCTGAEIE MIFSQGGEEGFVGRMVEESERLQTRCKWYTSMLGK MSSVSTIVQALRARSIMNYALTEFVQGQTRRWAIA WSFSDTHLPDAVSRISS (Gymnopilus dilepis (PSIM gene)) SEQ ID NO: 26 MHIRNPYLTPPDYEALAEAFPALKPYVTVNPDKTT TIDFAIPEAQRLYTAALLYRDFGLTITLPPDRLCP TVPNRLNYVLWIQDILQITSAALGLPEARQVKGVD IGTGAAAIYPILGCSLAKNWSMVGTEVEQKCIDIA RQNVISNGLQDRITITANTIDAPILLPLFEGDSNF EWEFTMCNPPFYDGAADMETSQDAKGFGFGVNAPH TGTVVEMATDGGEAAFVSQMVRESLHLKTRCRWFT SNLGKLKSLHEIVGLLREHQITNYAINEYVQGTTR RYAIAWSFTDLRLSDHLPRPPNPDLSALF (Saccharmyces cerevisiae (ARO1 gene)) SEQ ID NO: 27 ATGGTTCAACTAGCCAAGGTTCCAATACTAGGAAA CGATATAATACACGTTGGATATAATATACACGATC ATCTTGTAGAGACAATTATTAAACACTGTCCTTCT TCTACTTACGTCATCTGTAACGATACTAACCTTAG CAAGGTACCTTATTACCAGCAACTGGTTCTGGAGT TCAAAGCAAGTCTTCCCGAAGGCTCCAGACTACTA ACCTACGTGGTCAAACCGGGCGAGACGTCTAAGAG TAGGGAGACGAAGGCGCAGTTAGAGGATTATCTTT TAGTAGAAGGGTGCACTCGTGATACGGTCATGGTA GCCATCGGCGGAGGTGTCATCGGTGACATGATCGG TTTCGTAGCCTCCACGTTCATGAGAGGTGTGAGGG TAGTACAGGTTCCGACGTCTCTTTTAGCAATGGTA GACTCATCCATAGGCGGTAAAACGGCGATCGATAC TCCGCTAGGAAAGAACTTCATTGGAGCCTTTTGGC AGCCAAAATTTGTTCTTGTGGATATCAAGTGGCTT GAAACACTAGCTAAACGTGAATTTATCAACGGCAT GGCAGAAGTGATCAAGACAGCGTGCATCTGGAACG CTGATGAATTTACTCGTCTCGAATCCAACGCGTCA CTGTTCCTAAACGTAGTAAATGGTGCGAAAAATGT AAAGGTGACTAACCAGCTGACGAACGAGATAGATG AGATCAGCAACACGGATATTGAAGCCATGTTGGAC CATACTTATAAACTGGTATTAGAGAGTATTAAGGT TAAAGCGGAGGTGGTAAGCAGCGATGAAAGGGAGA GCAGTCTTAGGAACCTTTTAAACTTCGGGCATAGC ATAGGTCACGCGTATGAAGCCATACTGACACCCCA GGCTTTACATGGAGAGTGCGTATCCATCGGCATGG TAAAAGAAGCAGAACTATCAAGGTATTTTGGGATA CTTTCTCCGACCCAGGTGGCGCGTCTAAGCAAAAT TCTAGTTGCGTACGGATTGCCCGTTAGCCCCGATG AGAAATGGTTTAAAGAGCTTACACTTCATAAGAAG ACACCCTTGGACATACTGCTAAAGAAGATGAGCAT CGACAAGAAAAATGAAGGAAGCAAGAAGAAGGTCG TAATCCTAGAGTCTATCGGCAAATGTTACGGAGAC TCAGCTCAGTTTGTTTCAGACGAAGACTTACGTTT TATATTGACAGATGAAACACTAGTATATCCTTTTA AGGATATTCCCGCTGATCAGCAGAAAGTCGTGATT CCACCCGGAAGTAAATCAATAAGCAATCGTGCTTT AATCTTAGCAGCTCTGGGGGAGGGACAGTGCAAGA TCAAGAACCTATTACACTCCGACGACACCAAACAT ATGCTGACCGCAGTCCACGAGTTAAAAGGTGCTAC CATCAGTTGGGAGGATAACGGAGAAACAGTGGTCG TAGAGGGCCATGGCGGGAGCACTCTATCGGCTTGT GCTGATCCCTTATACTTAGGCAACGCGGGGACGGC GAGTAGATTCTTAACATCACTGGCGGCACTAGTGA ACAGTACATCCTCCCAAAAGTATATCGTACTAACA GGCAACGCAAGGATGCAGCAACGTCCGATAGCGCC CCTTGTTGACAGCTTACGTGCTAACGGGACAAAGA TCGAGTACTTGAACAACGAAGGTTCTTTGCCGATC AAAGTGTACACTGATTCTGTATTTAAAGGCGGCCG TATTGAGTTGGCTGCGACAGTTAGTTCCCAATACG TGAGCAGTATCCTGATGTGTGCGCCTTACGCAGAA GAGCCCGTGACTTTAGCTTTGGTAGGTGGGAAACC GATCAGTAAACTATACGTTGATATGACAATTAAGA TGATGGAAAAGTTCGGCATCAATGTGGAGACCTCA ACCACGGAACCCTACACATACTACATTCCGAAGGG GCATTACATTAATCCAAGTGAGTACGTAATCGAGA GCGACGCTTCATCCGCTACCTATCCGTTAGCATTC GCCGCAATGACCGGTACCACCGTAACAGTCCCCAA CATCGGCTTTGAATCTCTGCAGGGCGACGCTAGAT TCGCAAGAGACGTCCTAAAGCCGATGGGGTGTAAA ATCACCCAAACGGCTACGTCTACAACCGTCAGTGG ACCACCCGTCGGTACGCTAAAGCCATTAAAACACG TTGATATGGAACCAATGACAGACGCCTTCTTAACC GCATGCGTTGTAGCCGCAATCAGTCATGACTCCGA CCCCAATTCAGCGAACACTACTACTATCGAGGGGA TCGCAAACCAAAGGGTTAAAGAATGCAACAGAATC TTAGCGATGGCTACCGAGCTGGCAAAGTTTGGAGT AAAGACAACAGAACTTCCCGATGGCATACAGGTCC ATGGGCTAAATTCCATCAAGGACCTTAAAGTCCCA TCTGACAGCTCAGGACCCGTCGGAGTCTGTACTTA TGATGACCATAGGGTTGCCATGTCATTTTCCCTTT TGGCTGGCATGGTAAACAGTCAGAATGAGAGAGAT GAAGTGGCAAACCCAGTTAGGATCTTAGAGAGGCA CTGCACCGGAAAGACGTGGCCAGGCTGGTGGGACG TTCTGCACAGCGAACTTGGAGCGAAGCTGGATGGT GCCGAGCCGCTAGAATGCACATCCAAAAAGAACTC TAAGAAGAGCGTAGTCATAATAGGCATGAGAGCTG CGGGCAAAACTACTATCTCTAAGTGGTGCGCAAGT GCGCTGGGTTACAAGTTGGTAGATTTAGATGAATT GTTCGAGCAGCAGCATAATAACCAATCAGTAAAAC AATTTGTAGTCGAGAATGGTTGGGAGAAATTCAGA GAGGAAGAGACCAGGATATTCAAGGAGGTTATTCA AAATTACGGCGACGACGGGTATGTCTTTAGCACTG GGGGAGGGATCGTCGAATCCGCGGAGAGCAGGAAA GCACTAAAGGACTTCGCCAGTTCCGGTGGGTATGT GCTTCACTTACATCGTGATATAGAGGAGACGATAG TCTTCCTACAAAGTGATCCATCCAGGCCGGCGTAT GTTGAGGAGATTAGGGAGGTCTGGAACCGTAGAGA AGGCTGGTATAAAGAATGTAGTAATTTTAGCTTTT TCGCACCTCACTGTAGCGCAGAGGCGGAGTTTCAA GCACTTAGACGTTCATTCAGTAAGTATATAGCTAC GATCACGGGGGTCCGTGAAATAGAGATTCCTAGTG GGAGGAGTGCGTTTGTATGCTTAACTTTTGACGAT CTAACTGAGCAAACGGAGAATCTGACGCCTATATG CTACGGGTGTGAAGCCGTAGAGGTGCGTGTTGATC ATCTTGCCAATTATTCCGCAGACTTCGTTAGCAAG CAATTAAGCATACTGAGAAAAGCGACCGACAGTAT ACCCATTATCTTCACCGTCCGTACTATGAAACAAG GCGGTAATTTTCCCGATGAAGAGTTCAAGACATTG CGTGAGTTGTACGACATAGCTCTTAAAAACGGAGT GGAGTTCCTTGATTTGGAACTTACTCTGCCTACAG ATATACAGTACGAAGTCATCAACAAGAGAGGTAAT ACGAAGATCATTGGGTCTCATCATGACTTCCAGGG TTTGTACAGCTGGGACGATGCTGAATGGGAAAACA GATTCAATCAGGCACTGACTCTTGACGTAGATGTG GTGAAATTTGTGGGTACCGCGGTGAATTTCGAGGA CAACTTACGTTTGGAACATTTTCGTGACACGCACA AAAATAAACCACTAATAGCAGTTAACATGACGTCT AAGGGCTCAATCAGTAGGGTACTAAATAATGTATT GACTCCGGTTACTTCAGACCTTTTACCGAACAGCG CAGCGCCTGGTCAATTGACGGTTGCACAGATTAAT AAAATGTATACATCTATGGGAGGAATTGAGCCTAA AGAGCTATTTGTGGTGGGGAAGCCAATCGGCCACT CAAGATCACCTATACTACACAATACTGGGTATGAG ATTTTGGGTCTACCTCACAAATTCGATAAATTTGA GACGGAAAGCGCACAATTAGTGAAGGAGAAATTGT TAGACGGGAACAAGAATTTCGGTGGTGCAGCGGTG ACCATCCCTTTAAAGCTAGACATAATGCAGTACAT GGATGAACTTACGGACGCTGCGAAGGTGATTGGGG CGGTAAACACAGTAATCCCTTTGGGTAACAAGAAA TTCAAGGGTGATAATACGGACTGGTTAGGGATAAG GAACGCACTTATAAATAATGGTGTGCCCGAGTACG TGGGGCATACTGCCGGACTTGTAATAGGTGCTGGT GGTACCAGTAGGGCGGCACTGTACGCTTTGCATAG CTTAGGTTGCAAGAAGATCTTTATCATCAATAGAA CAACTAGTAAACTGAAGCCACTGATAGAATCACTA CCCTCCGAGTTTAACATCATTGGAATAGAGTCTAC GAAATCCATCGAGGAGATTAAAGAACACGTCGGAG TCGCTGTTAGCTGCGTGCCTGCCGATAAGCCCTTA GATGACGAGCTACTGAGTAAGTTAGAACGTTTCCT TGTCAAGGGTGCACATGCGGCTTTCGTCCCAACAC TGCTAGAGGCTGCCTATAAACCCAGCGTAACACCT GTTATGACCATAAGTCAGGACAAGTATCAATGGCA CGTGGTGCCGGGTTCCCAGATGCTGGTCCATCAAG GTGTTGCACAATTTGAAAAATGGACTGGTTTCAAG GGGCCCTTCAAAGCCATATTTGACGCCGTGACTAA AGAGTAA (Saccharomyces cerevisiae (ARO2 gene)) SEQ ID NO: 28 ATGTCCACATTCGGTAAACTTTTCCGTGTCACTAC ATACGGCGAGTCACACTGCAAATCTGTGGGGTGCA TAGTAGACGGCGTTCCGCCGGGCATGAGTTTAACC GAAGCGGACATTCAACCTCAGCTTACCCGTAGGAG GCCCGGTCAGAGCAAGTTATCCACCCCGAGGGACG AAAAGGACCGTGTAGAGATCCAAAGCGGAACGGAA TTTGGGAAGACACTTGGTACGCCTATCGCTATGAT GATTAAAAACGAGGATCAACGTCCGCACGATTACT CCGACATGGACAAGTTCCCTAGGCCGAGTCACGCC GATTTTACGTACTCAGAGAAATACGGAATAAAAGC CTCCAGCGGTGGGGGCCGTGCTTCCGCGAGAGAAA CCATTGGAAGAGTAGCATCCGGTGCAATAGCAGAG AAGTTCCTAGCACAGAACTCAAATGTTGAAATTGT CGCTTTCGTCACGCAAATAGGTGAGATCAAGATGA ACCGTGACAGTTTCGACCCAGAATTTCAACACCTT CTAAATACAATTACGAGGGAGAAGGTAGATAGCAT GGGTCCAATAAGATGCCCCGACGCTTCCGTCGCGG GATTGATGGTGAAGGAAATTGAAAAATATCGTGGG AACAAGGATTCTATTGGGGGTGTAGTAACTTGCGT AGTCAGAAATCTACCTACAGGGTTGGGTGAACCGT GTTTTGACAAACTGGAGGCGATGCTGGCACATGCC ATGTTATCCATACCAGCAAGTAAAGGATTTGAAAT AGGATCTGGCTTCCAGGGTGTAAGCGTACCAGGAA GCAAACACAATGATCCCTTTTACTTTGAAAAAGAG ACTAACCGTCTTCGTACAAAGACAAACAACTCCGG TGGGGTGCAAGGGGGCATCTCTAATGGTGAGAACA TTTACTTTTCCGTACCATTTAAGAGCGTGGCTACA ATAAGCCAAGAGCAAAAGACCGCAACTTACGATGG AGAAGAAGGAATCCTCGCAGCTAAGGGTAGGCACG ATCCTGCGGTCACACCGCGTGCAATTCCCATAGTG GAAGCTATGACCGCCCTAGTACTAGCAGATGCGTT ACTAATACAGAAAGCCAGGGATTTTTCTAGGTCAG TCGTACATTAA (Saccharomyces cerevisiae (ARO3 gene)) SEQ ID NO: 29 ATGTTCATCAAGAATGACCATGCTGGTGATAGAAA GAGACTAGAGGACTGGCGTATAAAGGGTTATGACC CTCTAACTCCGCCTGATTTGCTACAGCACGAGTTT CCTATATCAGCAAAAGGGGAAGAAAATATCATCAA GGCTCGTGATAGTGTATGTGATATACTGAACGGAA AGGATGACAGACTTGTGATAGTAATTGGACCCTGT TCTCTGCATGATCCGAAGGCGGCCTACGACTATGC CGACAGATTAGCCAAAATATCCGAAAAGCTGTCAA AAGATCTTTTAATTATCATGCGTGCATACCTAGAG AAGCCTCGTACAACCGTTGGATGGAAAGGGTTGAT AAACGACCCGGATATGAACAATAGTTTTCAGATTA ATAAAGGCCTTCGTATAAGCCGTGAGATGTTTATA AAACTAGTTGAGAAATTACCTATTGCAGGAGAAAT GCTTGACACGATTTCCCCTCAGTTCTTATCTGACT GTTTCTCACTAGGTGCAATTGGTGCTAGGACTACC GAGTCACAGTTACATCGTGAACTGGCCAGCGGTCT GTCTTTCCCCATTGGCTTTAAAAATGGTACCGATG GTGGCCTTCAAGTAGCAATTGATGCTATGAGAGCT GCGGCCCACGAACACTACTTTTTGTCTGTGACCAA ACCTGGCGTAACAGCGATTGTGGGAACTGAAGGGA ACAAGGACACCTTCCTAATCCTGAGAGGGGGCAAG AACGGGACTAATTTTGACAAGGAGTCAGTTCAAAA CACTAAGAAGCAATTGGAGAAGGCGGGCCTTACTG ACGATTCTCAGAAGAGAATCATGATAGACTGCAGC CATGGCAACTCAAATAAAGATTTCAAAAATCAACC CAAAGTCGCCAAGTGTATCTACGATCAACTAACCG AAGGAGAAAATAGTTTATGCGGGGTGATGATAGAG AGTAATATAAACGAAGGAAGACAGGATATTCCTAA GGAAGGCGGAAGAGAGGGTCTGAAGTACGGGTGTT CTGTGACAGACGCTTGCATAGGATGGGAGAGCACG GAACAGGTTTTGGAGCTGCTGGCAGAAGGGGTGCG TAATAGAAGGAAAGCCTTAAAGAAGTAA (Saccharomyces cerevisiae (ARO4 K2229L gene)) SEQ ID NO: 30 ATGAGCGAATCTCCGATGTTCGCCGCAAACGGCAT GCCTAAGGTAAATCAAGGGGCCGAGGAGGACGTGA GAATATTAGGTTATGACCCGCTTGCCAGTCCTGCA TTGCTTCAGGTACAGATTCCAGCAACGCCAACGTC CTTAGAAACAGCAAAAAGGGGACGTCGTGAAGCTA TAGACATCATCACTGGCAAGGACGACCGTGTCCTA GTAATAGTTGGTCCGTGCTCTATCCATGACCTTGA GGCTGCACAGGAGTATGCACTAAGGTTGAAGAAAT TGTCTGATGAACTGAAAGGTGATCTTAGTATAATC ATGCGTGCATATTTAGAGAAACCGCGTACGACGGT AGGCTGGAAAGGGCTAATTAACGATCCGGATGTGA ATAATACCTTTAACATCAACAAGGGTCTACAGAGT GCGCGTCAGTTATTCGTGAACTTAACAAATATCGG ACTGCCGATAGGCTCCGAGATGCTGGACACGATAT CTCCCCAGTATTTGGCTGACCTTGTTTCTTTTGGA GCTATAGGTGCAAGGACTACTGAGAGTCAGTTACA TAGAGAGTTGGCATCAGGACTTAGCTTCCCTGTAG GATTTAAGAACGGTACAGACGGCACTCTTAATGTC GCGGTCGATGCCTGCCAGGCAGCCGCCCATTCACA TCATTTTATGGGAGTGACATTACACGGGGTGGCCG CTATCACAACGACTAAAGGGAATGAGCACTGTTTT GTTATCCTTAGAGGAGGAAAGAAAGGTACGAATTA TGATGCGAAAAGTGTAGCAGAGGCCAAAGCGCAAC TTCCTGCCGGTTCAAACGGACTTATGATTGACTAT TCCCATGGAAACTCAAATAAGGACTTTAGGAATCA GCCAAAAGTTAACGATGTGGTATGCGAACAGATCG CGAACGGTGAAAATGCGATTACGGGTGTTATGATC GAGTCAAATATAAATGAAGGTAACCAAGGTATCCC GGCAGAGGGCAAAGCGGGCCTGAAGTACGGTGTAT CTATTACGGATGCCTGTATAGGTTGGGAGACAACC GAAGACGTCCTAAGGAAACTTGCCGCCGCGGTTAG ACAGAGACGTGAAGTCAATAAGAAGTAA (Escherichia coli (AROL gene)) SEQ ID NO: 31 ATGACCCAGCCATTATTTCTGATCGGTCCTCGTGG GTGCGGGAAAACGACGGTTGGCATGGCCTTAGCTG ACAGTTTGAATCGTAGATTCGTGGACACCGACCAG TGGCTACAGTCTCAGCTTAACATGACGGTGGCCGA AATTGTAGAACGTGAAGAATGGGCTGGTTTTCGTG CAAGAGAAACAGCCGCATTGGAAGCTGTGACGGCG CCTTCAACGGTGATAGCTACGGGAGGTGGTATTAT TTTGACCGAATTTAATAGGCACTTCATGCAGAATA ATGGCATAGTGGTTTACCTATGCGCTCCTGTGTCT GTCTTGGTAAACCGTTTGCAAGCCGCACCAGAAGA AGACTTGCGTCCAACCCTGACGGGGAAGCCACTGT CTGAGGAAGTGCAAGAGGTACTGGAGGAAAGGGAC GCTCTATACCGTGAGGTGGCTCACATCATAATTGA CGCTACGAATGAGCCATCACAGGTAATTTCTGAGA TCCGTTCAGCGTTGGCCCAAACCATCAATTGTTAA (Saccharomyces cerevisiae (TRP1 gene)) SEQ ID NO: 32 ATGTCAGTGATTAACTTTACAGGCTCCTCAGGTCC CTTGGTCAAGGTCTGCGGCTTGCAATCAACAGAGG CCGCTGAATGCGCCCTAGACTCAGATGCAGACCTT TTAGGCATCATCTGTGTCCCCAACAGAAAGCGTAC TATTGATCCTGTTATTGCGCGTAAGATCAGTTCTT TGGTCAAGGCGTATAAGAACTCCTCAGGAACCCCC AAGTATCTGGTAGGGGTATTCAGGAATCAACCTAA AGAAGACGTCTTGGCCCTAGTTAATGACTACGGCA TAGACATAGTCCAGTTGCACGGAGACGAAAGCTGG CAAGAATATCAGGAATTTTTGGGGCTGCCGGTTAT AAAAAGGCTGGTTTTCCCTAAGGACTGTAACATAC TGTTATCAGCCGCATCACAGAAGCCGCATTCCTTT ATACCTCTTTTCGACTCCGAGGCCGGAGGCACTGG TGAATTACTGGACTGGAACAGCATTTCAGATTGGG TAGGGAGGCAGGAGAGCCCAGAATCTCTTCATTTT ATGTTGGCAGGGGGCCTTACGCCGGAAAATGTTGG AGATGCATTGAGGTTGAACGGAGTTATAGGTGTGG ATGTCAGTGGTGGGGTTGAAACGAATGGTGTTAAA GACAGCAACAAAATAGCAAATTTTGTCAAGAATGC CAAAAAGTAA (Saccharomyces cerevisiae (TRP2 S76L gene)) SEQ ID NO: 33 ATGACGGCGAGCATTAAAATTCAGCCAGACATTGA CAGTTTAAAGCAGTTGCAGCAACAGAATGACGACT CTTCCATTAACATGTATCCCGTGTATGCGTATCTG CCTTCTTTGGATTTGACACCTCACGTTGCTTACTT AAAGTTAGCTCAACTTAATAATCCAGATAGAAAGG AGTCTTTCTTACTTGAAAGTGCTAAGACCAATAAT GAGCTGGACAGATATCTTTTCATAGGGATCAGTCC AAGGAAGACCATTAAGACCGGGCCCACTGAAGGCA TTGAGACTGACCCATTAGAAATCCTTGAAAAAGAA ATGTCTACTTTCAAAGTCGCCGAAAACGTCCCAGG CCTTCCCAAATTAAGCGGCGGGGCGATAGGTTACA TATCATACGACTGTGTACGTTACTTCGAACCCAAG ACTAGGCGTCCCTTGAAAGATGTGCTTAGGTTACC AGAGGCGTACTTGATGCTTTGTGACACGATAATCG CATTTGACAATGTCTTCCAAAGGTTTCAAATTATT CACAATATTAACACAAACGAAACGTCTTTGGAGGA AGGATACCAGGCGGCTGCGCAGATAATCACGGATA TTGTATCTAAGTTGACAGACGACAGCTCCCCCATT CCGTACCCGGAGCAACCCCCTATCAAACTAAACCA AACCTTTGAATCCAACGTAGGCAAAGAGGGGTATG AAAATCACGTCTCCACTCTCAAAAAGCACATAAAG AAAGGTGACATAATCCAAGGTGTGCCCAGCCAGAG AGTGGCGAGGCCTACATCTTTACATCCATTCAACA TATATAGGCATCTTAGAACCGTGAACCCATCACCT TATCTATTTTACATAGACTGCCTAGATTTCCAGAT AATAGGGGCTAGTCCCGAATTGCTGTGTAAATCAG ATTCAAAGAATCGTGTTATTACACACCCCATAGCT GGCACAGTCAAGAGGGGTGCTACCACTGAGGAAGA TGACGCTCTGGCAGATCAGCTACGTGGTTCTTTGA AAGATAGGGCTGAGCATGTTATGCTGGTTGACTTA GCAAGAAACGACATCAATCGTATATGCGATCCCCT AACGACTTCCGTTGACAAACTTTTGACCATTCAGA AGTTCAGCCACGTACAGCACTTAGTCTCTCAGGTC TCTGGCGTCCTAAGGCCTGAGAAAACTCGTTTCGA TGCATTCAGAAGCATATTTCCCGCGGGTACAGTGA GTGGGGCCCCAAAGGTGCGTGCAATGGAGCTTATA GCCGAGCTAGAAGGCGAGCGTAGGGGAGTGTACGC AGGGGCCGTAGGCCATTGGTCTTATGACGGCAAGA CCATGGATAATTGTATTGCACTAAGGACCATGGTC TATAAAGATGGGATTGCATACTTGCAGGCAGGAGG TGGGATTGTCTATGACAGCGATGAGTACGATGAGT ATGTAGAAACAATGAATAAAATGATGGCGAATCAT TCCACGATAGTGCAGGCGGAGGAGTTATGGGCGGA TATTGTGGGTAGTGCATAA (Saccharomyces cerevisiae (TRP3 gene)) SEQ ID NO: 34 ATGTCTGTCCACGCAGCCACCAACCCGATAAATAA GCATGTCGTTCTGATTGATAATTACGACTCCTTCA CGTGGAATGTTTATGAGTATCTTTGCCAGGAGGGA GCGAAGGTTAGCGTTTACCGTAATGACGCTATCAC GGTCCCAGAAATTGCAGCACTGAATCCCGATACCC TTCTGATATCACCAGGCCCGGGCCATCCCAAGACA GATTCTGGTATTAGCAGAGATTGCATCAGATACTT CACTGGAAAAATTCCAGTTTTTGGGATATGTATGG GGCAGCAATGCATGTTTGACGTGTTTGGCGGGGAA GTGGCTTATGCGGGTGAAATAGTGCACGGAAAGAC TAGTCCCATATCCCATGATAACTGCGGTATCTTTA AGAATGTCCCCCAGGGTATTGCAGTTACAAGATAT CATAGCTTGGCTGGCACTGAAAGTAGTCTGCCTAG CTGCCTAAAGGTGACTGCCTCTACTGAAAACGGGA TAATCATGGGGGTAAGGCACAAGAAGTACACCGTC GAGGGGGTGCAATTCCACCCAGAGAGTATTTTAAC CGAAGAAGGACATCTAATGATCCGTAATATTCTTA ATGTTTCTGGCGGAACGTGGGAGGAAAATAAATCA AGCCCATCCAATTCCATCCTAGATAGGATATACGC CAGGCGTAAAATTGACGTAAACGAACAGTCAAAGA TTCCCGGTTTCACCTTTCAGGACTTACAATCTAAC TATGATCTTGGCCTTGCCCCGCCTCTGCAAGATTT TTATACCGTGCTGAGCAGTAGTCATAAGAGGGCTG TGGTCCTAGCGGAGGTGAAGCGTGCCTCCCCTAGC AAAGGTCCAATCTGCCTGAAGGCCGTTGCTGCTGA ACAAGCCCTTAAATATGCTGAGGCTGGGGCGAGTG CAATTAGCGTTCTAACAGAACCCCACTGGTTCCAC GGGAGCCTTCAAGACCTTGTGAATGTAAGAAAGAT CTTGGATCTAAAATTTCCGCCAAAAGAGAGACCCT GCGTGCTTAGGAAAGAGTTTATATTTTCCAAATAC CAAATATTGGAGGCACGTCTAGCTGGTGCAGATAC TGTCCTTTTGATTGTAAAGATGTTGTCCCAACCAT TACTGAAAGAGCTATATAGTTACTCAAAGGATTTA AACATGGAGCCGTTAGTGGAAGTAAATAGCAAGGA GGAGCTACAACGTGCCCTGGAAATTGGTGCCAAGG TTGTTGGAGTTAACAATCGTGACTTGCATTCCTTC AACGTAGACTTGAATACAACAAGTAATTTGGTCGA ATCTATCCCAAAAGATGTGCTGTTGATTGCACTTT CCGGTATCACAACACGTGATGACGCCGAAAAGTAT AAAAAGGAGGGGGTGCACGGGTTTTTGGTGGGTGA GGCGTTAATGAAATCTACAGATGTAAAGAAGTTTA TTCATGAGCTGTGCGAATAA (Saccharomyces cerevisiae (TRP4 gene)) SEQ ID NO: 35 ATGAGCGAAGCTACTCTATTAAGTTATACCAAAAA GCTACTAGCAAGCCCACCTCAGCTTAGTTCCACCG ACCTACACGATGCACTACTTGTCATCCTAAGTCTA CTTCAGAAGTGCGACACCAATTCTGATGAGTCCTT GTCTATTTATACGAAGGTGTCTTCCTTTTTAACAG CCCTAAGGGTGACTAAGTTAGATCATAAGGCGGAA TATATTGCCGAGGCTGCAAAAGCAGTTTTGCGTCA CTCAGATCTGGTCGATCTACCTTTACCTAAAAAGG ATGAGCTGCATCCTGAAGATGGTCCTGTTATCTTG GACATTGTGGGTACTGGGGGTGATGGACAGAATAC CTTTAACGTGTCAACGTCAGCCGCTATTGTGGCCT CAGGTATTCAGGGACTGAAGATTTGCAAACACGGA GGTAAAGCATCTACCTCAAACAGCGGAGCTGGAGA TCTGATTGGGACATTGGGATGCGATATGTTCAAAG TGAATAGTAGCACAGTCCCCAAATTGTGGCCAGAC AATACATTTATGTTCTTATTGGCTCCATTCTTTCA TCATGGGATGGGTCATGTAAGCAAGATTCGTAAGT TTCTTGGAATACCTACGGTATTTAACGTATTGGGG CCGCTGTTACACCCCGTATCCCATGTGAATAAGAG GATACTTGGAGTGTATTCAAAAGAGTTGGCGCCAG AATATGCGAAGGCAGCAGCCTTGGTCTATCCAGGG TCAGAAACGTTTATTGTGTGGGGCCATGTTGGGCT TGACGAGGTGAGCCCCATAGGAAAGACTACCGTGT GGCACATCGATCCGACAAGCTCAGAACTAAAGTTG AAGACCTTCCAGCTGGAGCCATCTATGTTCGGTCT GGAGGAGCACGAGCTGAGTAAATGCGCCTCATATG GACCTAAGGAGAATGCTCGTATATTAAAGGAGGAA GTCCTTTCCGGCAAATACCACCTAGGCGACAATAA TCCAATATATGATTACATTCTGATGAATACTGCAG TATTATACTGCCTGTCCCAAGGGCACCAAAACTGG AAGGAAGGTATTATCAAAGCCGAGGAGTCAATTCA CAGCGGGAATGCCTTGAGATCGCTAGAACATTTCA TTGATTCAGTATCTTCCCTTTAA (Saccharomyces cerevisiae (TAT2 gene)) SEQ ID NO: 36 ATGACCGAAGATTTCATCAGTAGCGTCAAAAGGTC AAATGAAGAGCTTAAAGAGAGAAAATCTAATTTTG GGTTTGTAGAGTACAAGTCAAAACAACTTACCTCC AGTAGCTCACACAACTCCAACTCTTCACACCATGA TGACGACAACCAGCACGGTAAAAGAAACATCTTTC AGCGTTGTGTGGATTCTTTTAAATCCCCTCTGGAT GGGTCTTTCGACACCTCCAATCTGAAAAGAACACT GAAACCTCGTCATTTAATAATGATCGCAATAGGAG GTAGTATAGGTACTGGTCTTTTCGTGGGTTCAGGG AAGGCTATAGCGGAAGGCGGACCACTTGGCGTTGT GATCGGATGGGCCATTGCGGGTAGCCAAATAATAG GTACTATACATGGGTTAGGAGAGATCACGGTAAGA TTTCCAGTAGTCGGTGCGTTTGCCAACTACGGCAC CCGTTTCTTGGACCCGAGCATTAGTTTTGTAGTCT CCACTATATACGTGCTACAGTGGTTCTTTGTCCTA CCCCTAGAGATTATTGCTGCGGCGATGACCGTGCA ATACTGGAACAGTTCTATCGATCCGGTAATATGGG TCGCAATTTTCTATGCCGTCATCGTCTCAATCAAT TTGTTTGGAGTTAGGGGTTTCGGAGAAGCTGAATT CGCCTTCTCAACTATTAAGGCAATCACTGTCTGTG GCTTCATAATCTTATGTGTAGTCTTGATCTGCGGC GGAGGACCCGATCACGAATTCATTGGTGCTAAATA CTGGCATGATCCTGGCTGCCTGGCAAACGGGTTTC CTGGAGTCTTGAGTGTCCTTGTCGTTGCGTCATAC AGCCTAGGAGGCATAGAAATGACTTGCTTAGCCTC TGGGGAAACGGACCCAAAGGGACTTCCCTCAGCTA TAAAACAGGTTTTCTGGCGTATTTTGTTTTTCTTC TTAATTTCTTTAACTCTAGTGGGATTTTTAGTTCC TTACACCAACCAAAATCTACTAGGTGGCTCCTCTG TCGATAATAGTCCCTTCGTTATCGCGATTAAGCTA CACCATATCAAAGCTCTTCCGTCTATTGTTAACGC AGTTATCCTTATTTCCGTGCTATCCGTGGGTAACA GTTGCATCTTTGCCAGCTCCAGAACTCTGTGTAGC ATGGCACATCAAGGACTGATACCGTGGTGGTTCGG CTATATTGACAGAGCTGGCAGACCCCTGGTTGGGA TTATGGCCAATTCTCTTTTCGGCTTATTGGCGTTC CTTGTTAAATCTGGCTCCATGAGTGAGGTGTTTAA TTGGCTGATGGCTATAGCCGGACTGGCGACATGTA TTGTGTGGTTATCTATAAATCTTTCCCATATAAGA TTCCGTCTTGCAATGAAGGCCCAAGGAAAGTCCCT GGATGAACTTGAATTCGTAAGCGCGGTTGGTATAT GGGGATCTGCTTATTCCGCACTTATCAATTGCTTA ATACTTATTGCTCAATTTTATTGCTCTTTATGGCC AATCGGGGGTTGGACATCCGGAAAAGAGAGGGCAA AGATTTTCTTTCAGAATTATCTTTGCGCCCTGATT ATGTTATTTATATTCATCGTCCATAAGATCTATTA TAAATGTCAAACGGGAAAGTGGTGGGGTGTTAAAG CTCTGAAGGACATCGACCTAGAGACCGACAGGAAG GACATAGACATCGAAATAGTTAAACAAGAAATCGC TGAAAAGAAGATGTATTTGGACTCCAGACCTTGGT ACGTGAGGCAGTTTCATTTTTGGTGCTAA
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/878,858 US20220389467A1 (en) | 2019-11-15 | 2022-08-01 | Biosynthetic production of psilocybin and related intermediates in recombinant organisms |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962936387P | 2019-11-15 | 2019-11-15 | |
US17/099,539 US11441164B2 (en) | 2019-11-15 | 2020-11-16 | Biosynthetic production of psilocybin and related intermediates in recombinant organisms |
US17/878,858 US20220389467A1 (en) | 2019-11-15 | 2022-08-01 | Biosynthetic production of psilocybin and related intermediates in recombinant organisms |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/099,539 Continuation US11441164B2 (en) | 2019-11-15 | 2020-11-16 | Biosynthetic production of psilocybin and related intermediates in recombinant organisms |
Publications (1)
Publication Number | Publication Date |
---|---|
US20220389467A1 true US20220389467A1 (en) | 2022-12-08 |
Family
ID=75909886
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/099,539 Active US11441164B2 (en) | 2019-11-15 | 2020-11-16 | Biosynthetic production of psilocybin and related intermediates in recombinant organisms |
US17/878,858 Abandoned US20220389467A1 (en) | 2019-11-15 | 2022-08-01 | Biosynthetic production of psilocybin and related intermediates in recombinant organisms |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/099,539 Active US11441164B2 (en) | 2019-11-15 | 2020-11-16 | Biosynthetic production of psilocybin and related intermediates in recombinant organisms |
Country Status (3)
Country | Link |
---|---|
US (2) | US11441164B2 (en) |
CA (1) | CA3155976A1 (en) |
WO (1) | WO2021097452A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2021514682A (en) | 2018-03-08 | 2021-06-17 | ニュー アトラス バイオテクノロジーズ エルエルシー | How to produce tryptamine |
JP2022550463A (en) | 2019-10-01 | 2022-12-01 | エンピリアン ニューロサイエンス, インコーポレイテッド | Genetic engineering of fungi to modulate tryptamine expression |
EP4153564A4 (en) | 2020-05-19 | 2024-06-19 | Cybin IRL Limited | Deuterated tryptamine derivatives and methods of use |
CN113371848B (en) * | 2021-06-29 | 2022-09-16 | 内蒙古阜丰生物科技有限公司 | Comprehensive treatment process of amino acid wastewater |
WO2023015279A1 (en) * | 2021-08-05 | 2023-02-09 | Miami University | Methods for the production of methylated tryptamine derivatives, intermediates or side products |
WO2023081829A2 (en) * | 2021-11-05 | 2023-05-11 | Miami University | Methods for the improved production of psilocybin and intermediates or side products through enzyme optimization |
AU2022381203A1 (en) * | 2021-11-05 | 2024-05-16 | Miami University | Methods for the production of tryptophans, tryptamines, intermediates, side products and derivatives |
CA3241326A1 (en) | 2021-12-03 | 2023-06-08 | Medicinal Genomics Corporation | Psilocybe assay |
EP4223883A1 (en) | 2022-02-02 | 2023-08-09 | Infinit Biosystems | Process for producing tryptamines |
WO2024059493A1 (en) | 2022-09-13 | 2024-03-21 | Medicinal Genomics Corporation | Psilocybe assay |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8809059B2 (en) * | 2007-09-21 | 2014-08-19 | Basf Plant Science Gmbh | Plants with increased yield |
CN103987840A (en) | 2011-08-08 | 2014-08-13 | 国际香料香精公司 | Compositions and methods for the biosynthesis of vanillin or vanillin beta-D-glucoside |
US20170159047A9 (en) | 2014-08-29 | 2017-06-08 | Massachusetts Institute Of Technology | Composability and design of parts for large-scale pathway engineering in yeast |
US20160298151A1 (en) | 2015-04-09 | 2016-10-13 | Sher Ali Butt | Novel Method for the cheap, efficient, and effective production of pharmaceutical and therapeutic api's intermediates, and final products |
JP2021514682A (en) * | 2018-03-08 | 2021-06-17 | ニュー アトラス バイオテクノロジーズ エルエルシー | How to produce tryptamine |
FI129102B (en) * | 2018-03-19 | 2021-07-15 | Teknologian Tutkimuskeskus Vtt Oy | Heterologous production of psilocybin |
US20220372494A1 (en) | 2019-10-28 | 2022-11-24 | Miami University | Methods for the production of psilocybin and intermediates or side products |
-
2020
- 2020-11-16 WO PCT/US2020/060788 patent/WO2021097452A2/en active Application Filing
- 2020-11-16 CA CA3155976A patent/CA3155976A1/en active Pending
- 2020-11-16 US US17/099,539 patent/US11441164B2/en active Active
-
2022
- 2022-08-01 US US17/878,858 patent/US20220389467A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2021097452A2 (en) | 2021-05-20 |
US11441164B2 (en) | 2022-09-13 |
CA3155976A1 (en) | 2021-05-20 |
US20210147888A1 (en) | 2021-05-20 |
WO2021097452A3 (en) | 2021-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220389467A1 (en) | Biosynthetic production of psilocybin and related intermediates in recombinant organisms | |
US11136293B2 (en) | Processes for the production of tryptamines | |
Zhang et al. | Integration of ARTP mutagenesis with biosensor-mediated high-throughput screening to improve L-serine yield in Corynebacterium glutamicum | |
Liu et al. | Biosensor-based evolution and elucidation of a biosynthetic pathway in Escherichia coli | |
TW202039823A (en) | Genetically modified microorganism and method both for producing nicotinamide derivative, and vector for use in same | |
US9512449B2 (en) | Method for producing phenol from renewable resources by fermentation | |
EP2889378B1 (en) | Method for producing hydroxy-l-lysine employing an l-lysine hydroxylase and method for producing hydroxy-l-pipecolic acid | |
KR20120088753A (en) | Microorganisms for the production of aniline | |
CN108463555A (en) | The method for producing benzaldehyde | |
Kuivanen et al. | Engineering of Saccharomyces cerevisiae for anthranilate and methyl anthranilate production | |
Jiang et al. | High-yield ectoine production in engineered Corynebacterium glutamicum by fine metabolic regulation via plug-in repressor library | |
Tsunematsu et al. | Enzymatic Amide Tailoring Promotes Retro‐Aldol Amino Acid Conversion To Form the Antifungal Agent Aspirochlorine | |
Ren et al. | Engineering substrate and energy metabolism for living cell production of cytidine‐5′‐diphosphocholine | |
US11932896B2 (en) | Host cells and methods for producing hydroxytyrosol | |
Liu et al. | The 138th residue of acetohydroxyacid synthase in Corynebacterium glutamicum is important for the substrate binding specificity | |
Xu et al. | Combining precursor-directed engineering with modular designing: an effective strategy for de novo biosynthesis of L-DOPA in Bacillus licheniformis | |
EP3219805B1 (en) | Method for manufacturing cis-5-hydroxy-l-pipecolic acid | |
US10920231B2 (en) | Systems and methods for enhancing gene expression | |
Ferrer et al. | L-serine biosensor-controlled fermentative production of l-tryptophan derivatives by Corynebacterium glutamicum. Biology. 2022; 11: 744 | |
CN108424859B (en) | Construction and application of gene engineering bacteria for producing citicoline | |
CN110241062A (en) | New escherichia expression system | |
Peng et al. | Heterologous naringenin production in the filamentous fungus Penicillium rubens | |
Henríquez et al. | Whole cell biosynthetic activity of Komagataella phaffii (Pichia pastoris) GS115 strains engineered with transgenes encoding Chromobacterium violaceum ω‐transaminase alone or combined with native transketolase | |
WO2024013212A1 (en) | Microbial cell factories producing thiamine | |
CN113817659B (en) | Method for preparing beta-alanine by metabolic engineering escherichia coli fermentation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: CB THERAPEUTICS, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:VOGAN, JACOB MICHAEL;PEIFFER, LAURA FLATAUER;WADE, JAMES LEE;AND OTHERS;SIGNING DATES FROM 20210629 TO 20210715;REEL/FRAME:060690/0603 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |